National and Local Antibiotic Prescribing Trends and Prescribing Appropriateness in Older Adults by Alotaibi, Fawaz M
Virginia Commonwealth University 
VCU Scholars Compass 
Theses and Dissertations Graduate School 
2019 
National and Local Antibiotic Prescribing Trends and Prescribing 
Appropriateness in Older Adults 
Fawaz M. Alotaibi 
Virginia Commonwealth University 
Follow this and additional works at: https://scholarscompass.vcu.edu/etd 
 Part of the Other Pharmacy and Pharmaceutical Sciences Commons 
 
© The Author 
Downloaded from 
https://scholarscompass.vcu.edu/etd/5714 
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It 
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars 
Compass. For more information, please contact libcompass@vcu.edu. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Fawaz Alotaibi, 2019 
All Rights Reserved 
  
 
NATIONAL AND LOCAL ANTIBIOTIC PRESCRIBING TRENDS AND PRESCRIBING 
APPROPRIATENESS IN OLDER ADULTS 
 
 
 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University 
 
 
by  
Fawaz Mutlaq Alotaibi 
Pharm.D., College of Clinical Pharmacy, King Faisal University,  
Kingdom of Saudi Arabia, 2011 
 Master of Pharmaceutical Sciences, Department of Pharmacotherapy and Outcomes 
Science, School of Pharmacy,  
Virginia Commonwealth University, Richmond, VA, USA, 2015   
Doctoral Candidate, Department of Pharmacotherapy and Outcomes Science,  
School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA, 2019  
 
 
Advisor: 
Patricia W. Slattum, Pharm.D., Ph.D., BCGP 
Director, Geriatric Pharmacotherapy Program 
Victor A. Yanchick Professor of Pharmacotherapy and Outcomes Science 
 
 
 
Virginia Commonwealth University, Richmond, VA 
March, 2019 
 
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedications 
 
This work is dedicated to the love of my life, my mother Munerah, and my father Mutlaq   
 
 iii 
Acknowledgments 
    First, I would like to thank God for the endless blessings, well-being, and help 
bestowed on me to accomplish this work.  
    Secondly, I would like to express my gratitude, respect, and appreciation to my 
research committee chair Dr. Patricia Slattum, who gave me every single opportunity to 
be where I am right now. I have learned everything that graduate student wish to learn 
from her over the past five years from research techniques, communication skills, 
writing skills, multitasking, working smarter not harder, and a lot more personally and 
professionally. She helped me to build my CV with different professional certificates and 
expand my research scope to cover epidemiological studies and pharmacy education 
studies, valuable publications in different research topics, and encouraged and support 
me to present my work in national conferences. She was always looking for our future 
and how to make the best of us as a graduate students in the geriatrics 
pharmacotherapy research group. I sincerely appreciate her wisdom, valuable feedback 
on my writing, myself personally, my research projects and my future plans as well. I’m 
sure all of these skills that she built in me would help me in my future career. I will 
always try to be like her personally and professionally. Thank you Dr. Slattum.  
    I would like to thank my committee member Dr. McRae for her feedback on my 
writing and feedback on my projects. Also, I would like to thank Dr. Amy Pakyz for 
serving in my committee and sharing her amazing experience and knowledge in the 
infectious diseases. I would like to Thank Dr. D’Arcy Mays for his understanding to be a 
committee member in my research committee after Dr. Saba Masho passed away. You 
are always there to help and answer all my stat questions. I know Dr. Masho won’t read 
 
 iv 
this, but her soul is here with us and she is in my prayers all the time. I am so lucky that 
I had the chance to be in her class (Principle of Epidemiology, fall 2014). Dr. Masho is 
one of kindest person I have ever met, she will be missed. Also, I would like to thank Dr. 
Tammy Nguyen for her positive energy, understanding, and the clinical feedback that 
she provided me in my projects.  
    In the past seven years (the golden period in my life), I have met wonderful friends 
and some of them I consider brothers and sisters who made my journey in the State 
unforgettable and excited. Thank you very much to every one of you. Also, I would like 
to thank the faculty, current and former graduate students in the Geriatrics 
Pharmacotherapy Research Group from fall 2013 to spring 2019.  
    I would like thank the Kingdom of Saudi Arabia for its generosity supporting me 
financially and providing all the support to be successful in my graduate school. Without 
their financial support, I wouldn’t have the chance to fly to America and experience this 
amazing, unforgettable period in my life.  
    Finally, I would like to thank my parents, my brothers, and my sisters without their 
prayers and supports I wouldn’t complete this work. Thank you very much.  
 
  
 
 v 
TABLE OF CONTENTS  
 
Acknowledgments ........................................................................................................... iii 
List of Tables .................................................................................................................. vii 
List of Figures ..................................................................................................................ix 
ABSTRACT .....................................................................................................................xi 
CHAPTER ONE: INTRODUCTION ................................................................................. 1 
Antibiotic Therapy: ....................................................................................................... 2 
Antibiotic Complications: .............................................................................................. 6 
Antibiotic Stewardship Programs (ASPs): .................................................................... 8 
The Older Adult Population: ....................................................................................... 10 
Geriatrics Clinic and Adult Internal Medicine Ambulatory Clinic at VCU Health: ........ 13 
Antibiotic Appropriateness: ........................................................................................ 14 
Rational (Significance): .............................................................................................. 16 
Specific Aims: ............................................................................................................ 18 
Summary: .................................................................................................................. 21 
References: ............................................................................................................... 22 
CHAPTER TWO 
Study 1: The Trend of Antibiotic Use Among Community-Dwelling Older Adults in 
The United States (Medical Expenditure Panel Survey MEPS 2011-2015) ............. 27 
Background: .............................................................................................................. 28 
Methods: .................................................................................................................... 30 
Results: ...................................................................................................................... 33 
Discussion: ................................................................................................................ 39 
Conclusions: .............................................................................................................. 42 
 
 vi 
References: ............................................................................................................... 43 
CHAPTER THREE 
Study 2: A Comparison of Antibiotic Use and Infectious Diseases Among Older 
Adult Patients of VCU Health’s Geriatrics and Internal Medicine Ambulatory Care 
Clinics .......................................................................................................................... 46 
Background: .............................................................................................................. 47 
Methods: .................................................................................................................... 49 
Results: ...................................................................................................................... 56 
Discussion: ................................................................................................................ 67 
Conclusion: ................................................................................................................ 71 
References: ............................................................................................................... 72 
CHAPTER FOUR 
Study 3: Antibiotic Use Among Older Adults Visiting The Emergency Department 
at VCU Health from 2012-2017 ................................................................................... 77 
Background: .............................................................................................................. 78 
Methods: .................................................................................................................... 80 
Results: ...................................................................................................................... 87 
Discussion: ................................................................................................................ 98 
Conclusion: .............................................................................................................. 100 
References: ............................................................................................................. 101 
CHAPTER FIVE: DISCUSSION ................................................................................. 104 
Summary of Findings: .............................................................................................. 105 
Implications: ............................................................................................................. 109 
Future Research: ..................................................................................................... 110 
References: ............................................................................................................. 112 
 
 
 vii 
List of Tables 
TABLE 1.1. A SUMMARY OF THE RECENT STUDIES THAT EXAMINE THE ANTIBIOTICS RATE AMONG 
US POPULATION .......................................................................................................... 4 
TABLE 1.2. THE CDC’S ESSENTIAL CORE ELEMENTS FOR ANTIBIOTIC STEWARDSHIP PROGRAMS
 ................................................................................................................................. 8 
TABLE 2.1. THE DEMOGRAPHIC CHARACTERISTICS OF ANTIBIOTIC USERS AND NON-USERS IN 
MEPS FROM 2011-2015. ......................................................................................... 35 
TABLE 2.2. MULTIPLE LOGISTIC REGRESSION ANALYSIS PREDICTING ANTIBIOTIC USERS VS. NON-
USERS ..................................................................................................................... 36 
TABLE 3.1. THE ICD-9-CM AND ICD-10-CM CODES FOR EACH INFECTIOUS DISEASES 
INCLUDED IN THE STUDY. ........................................................................................... 54 
TABLE 3.2. ANTIBIOTICS APPROPRIATENESS CRITERIA ACCORDING TO FLEMING-DUTRA ET AL.
 ............................................................................................................................... 55 
TABLE 3.3. DEMOGRAPHIC CHARACTERISTICS AMONG THOSE WHO WERE PRESCRIBED 
ANTIBIOTICS IN BOTH AMBULATORY CARE CLINICS FROM 2012 TO 2017 ......................... 60 
TABLE 3.4. ANTIBIOTIC APPROPRIATENESS BETWEEN GERIATRICS CLINIC AND INTERNAL 
MEDICINE AMBULATORY CLINIC. ................................................................................. 61 
TABLE 3.5. MULTIPLE LOGISTIC REGRESSION MODELING ASSESSING PREDICTORS OF ANTIBIOTIC 
APPROPRIATENESS AMONG OLDER ADULTS VISITING GERIATRICS CLINIC AND INTERNAL 
MEDICINE AMBULATORY CLINIC FROM 2012-2017. ...................................................... 62 
TABLE 4.1. ICD-9-CM AND ICD-10-CM CODES FOR EACH INFECTIOUS DISEASE INCLUDED IN 
THE STUDY. .............................................................................................................. 85 
TABLE 4.2. ANTIBIOTIC APPROPRIATENESS CRITERIA ACCORDING TO FLEMING-DUTRA, ET AL. 86 
 
 viii 
TABLE 4.3. DEMOGRAPHIC CHARACTERISTICS OF THOSE WHO RECEIVED ANTIBIOTICS IN THE 
EMERGENCY DEPARTMENT AT VCU HEALTH BY AGE GROUP FROM 2012 TO 2017. ........ 91 
TABLE 4.4. ANTIBIOTIC PRESCRIBING APPROPRIATENESS BY AGE GROUP AT THE EMERGENCY 
DEPARTMENT, VCU HEALTH FROM 2012-2017. .......................................................... 92 
TABLE 4.5. MULTIPLE LOGISTIC REGRESSION MODEL ASSESSING PREDICTORS OF ANTIBIOTIC 
APPROPRIATENESS AMONG OLDER ADULTS AND MIDDLE-AGED PATIENTS VISITING THE 
EMERGENCY DEPARTMENT AT VCU HEALTH FROM 2012-2017. ................................... 92 
 
  
 
 ix 
List of Figures 
FIGURE 1.1. U.S. POPULATION AGES 65 AND OLDER, 1950 TO 2050.25 ............................. 10 
FIGURE 2.1. THE TREND OF INFECTIOUS DISEASES AMONG OLDER ADULTS USING MEPS 2011-
2015. ...................................................................................................................... 37 
FIGURE 2.2. THE RATE OF ANTIBIOTIC PRESCRIPTIONS PER 1000 PRESCRIPTIONS AMONG 
OLDER ADULTS USING MEPS 2011-2015. .................................................................. 38 
FIGURE 3.1. THE TREND OF INFECTIOUS DISEASES DIAGNOSED AMONG OLDER ADULTS (65 
YEARS AND OLDER) IN INTERNAL MEDICINE AND GERIATRICS CLINIC PER 10,000 VISITS AT 
VCU HEALTH FROM 2012-2017 ................................................................................ 63 
FIGURE 3.2. THE TREND OF ANTIBIOTIC PRESCRIBING AMONG OLDER ADULTS (65 YEARS AND 
OLDER) IN INTERNAL MEDICINE AND GERIATRICS CLINIC PER 10,000 VISITS AT VCU 
HEALTH FROM 2012-2017 ........................................................................................ 64 
FIGURE 3.3. THE TREND OF ANTIBIOTIC TREATMENT FOR UTI AMONG OLDER ADULTS (65 YEARS 
AND OLDER) IN INTERNAL MEDICINE AND GERIATRICS CLINIC PER 10,000 VISITS AT VCU 
HEALTH FROM 2012-2017 ........................................................................................ 65 
FIGURE 3.4. THE TREND OF ANTIBIOTIC TREATMENT FOR URI AMONG OLDER ADULTS (65 YEARS 
AND OLDER) IN INTERNAL MEDICINE AND GERIATRICS CLINIC PER 10,000 VISITS AT VCU 
HEALTH FROM 2012-2017 ........................................................................................ 66 
FIGURE 3.5. THE TREND OF ANTIBIOTIC TREATMENT FOR SKIN INFECTIONS AMONG OLDER 
ADULTS (65 YEARS AND OLDER) IN INTERNAL MEDICINE AND GERIATRICS CLINIC PER 
10,000 VISITS AT VCU HEALTH FROM 2012-2017 ...................................................... 67 
 
 x 
FIGURE 4.1. THE TREND OF INFECTIOUS DISEASE DIAGNOSES PER 10,000 VISITS AMONG OLDER 
ADULTS (65 YEARS AND OLDER) AND MIDDLE- AGED ADULTS (54-64 YEARS) IN THE 
EMERGENCY DEPARTMENT AT VCU HEALTH FROM 2012-2017 .................................... 93 
FIGURE 4.2. THE TREND OF ANTIBIOTIC PRESCRIPTIONS PER 10,000 VISITS AMONG OLDER 
ADULTS (65 YEARS AND OLDER) AND MIDDLE-AGED ADULTS (54-64 YEARS) IN THE 
EMERGENCY DEPARTMENT AT VCU HEALTH FROM 2012-2017 .................................... 94 
FIGURE 4.3. THE TREND OF ANTIBIOTIC PRESCRIBING FOR UTI PER 100 UTI DIAGNOSES AMONG 
OLDER ADULT PATIENTS (65 YEARS AND OLDER) AND MIDDLE-AGED ADULTS (54-64 YEARS) 
IN THE EMERGENCY DEPARTMENT AT VCU HEALTH FROM 2012-2017 .......................... 95 
FIGURE 4.4. THE TREND OF ANTIBIOTIC PRESCRIBING FOR URI PER 100 URI DIAGNOSES 
AMONG OLDER ADULT PATIENTS (65 YEARS AND OLDER) AND MIDDLE-AGED ADULTS (54-64 
YEARS) IN THE EMERGENCY DEPARTMENT AT VCU HEALTH FROM 2012-2017. .............. 96 
FIGURE 4.5. THE TREND OF ANTIBIOTIC PRESCRIBING FOR SKIN INFECTIONS PER 100 SKIN 
INFECTION DIAGNOSES AMONG OLDER ADULT PATIENTS (65 YEARS AND OLDER) AND 
MIDDLE-AGED ADULTS (54-64 YEARS) IN THE EMERGENCY DEPARTMENT AT VCU HEALTH 
FROM 2012-2017 ..................................................................................................... 97 
 
  
 
 xi 
ABSTRACT 
NATIONAL AND LOCAL ANTIBIOTIC PRESCRIBING TRENDS AND PRESCRIBING 
APPROPRIATENESS IN OLDER ADULTS 
By Fawaz Alotaibi, Ph.D. Candidate., MS., Pharm.D. 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University. 
Virginia Commonwealth University, 2019 
Advisor: Patricia W. Slattum, Pharm.D., Ph.D., BCGP 
Director, Geriatric Pharmacotherapy Program 
Victor A. Yanchick Professor of Pharmacotherapy and Outcomes Science 
Background: Antibiotic overuse/misuse has been documented in several reports to 
increase the risk of Clostridioides difficile (C.diff) infection and antibiotic resistance. The 
older adult population is more prone to use antibiotic medications than any other age 
group due to decreased immune function, use of urinary catheters, ventilation during 
hospitalization and other factors. Antibiotic resistance and C.diff are major public health 
problems. However, studies examining the trends of antibiotic use and the association 
between the antibiotic use and negative health outcomes among older adults in the 
outpatient and emergency department settings are limited.  
Objectives: The main objectives of this dissertation were to: 1) calculate the national 
antibiotic trends among community-dwelling older adults in the United State; 2) evaluate 
the antibiotic trends and antibiotic appropriateness among older adult patients visiting 
the geriatrics clinic and adult internal ambulatory care clinic at VCU Health; and 3) 
 
 xii 
examine the antibiotic trends and antibiotic appropriateness among older adult patients 
and middle-aged patients visiting the emergency department at VCU Health.  
Methods: For the first objective, data were obtained from Medical Expenditure Panel 
survey (MEPS) a nationally representative dataset (2011-2015). Descriptive analyses 
were conducted and multiple logistic regression was performed to assess the 
association between the antibiotic use and demographic and sociodemographic 
characteristics. In the second objective, data were obtained from VCU Health outpatient 
clinics (geriatrics, and Internal medicine ambulatory care clinic only). Descriptive 
statistics were calculated and multiple logistic regression was performed to assess the 
association between antibiotic appropriateness and type of clinics and other 
demographic characteristics. In the third objective, the emergency department 
electronic medical records at VCU were used. Trend analysis was performed across the 
dissertation studies using the Cochran–Armitage test. All variables were considered 
statistically significant at an α level of 0.05. All the statistical analyses were conducted 
using the Statistical Analysis Software Version 9.4 (SAS v.9.4), (SAS Institute Inc, Cary, 
NC).        
Results: There were 105,762,134 prescriptions dispensed to older adults in the 
outpatient setting in the US from 2011 to 2015. Antibiotic prescriptions were more 
common among women (18%) compared to men (12%). White participants received 
more antibiotics (27%) than African Americans (1.77%) and others (1.4%). 
Among the 3,515 patients who visited either Geriatrics or Internal Medicine ambulatory 
clinic at VCU Health from 2012-2017, 1,534 antibiotics were prescribed. Potentially 
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inappropriate antibiotic prescriptions were similar between the two clinics (30% in 
Geriatrics clinic and 28% in Internal Medicine ambulatory clinic) with p-value of 0.08. 
In addition, 6,343 middle-aged or older adult patients were dispensed and prescribed an 
antibiotic in the ED at VCU Health from (2012 to 2017). Eighteen percent of the 
antibiotic prescriptions received by middle age group were considered potentially 
inappropriate, compared to 9% among the older adult patient (p < 0.0001).   
Conclusions: The rate of antibiotic use overall remains unchanged despite the national 
and international efforts to reduce antibiotic prescriptions and eventually to reduce 
antibiotic resistance. The changes in the patterns of use in some of the antibiotic 
categories appear to be driven more by the safety concerns rather than reducing overall 
use. Future research is needed to strengthen antibiotic stewardship programs for older 
adults in outpatient settings. 
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CHAPTER ONE: INTRODUCTION 
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Antibiotic Therapy:  
    Antibiotics are one of the most significant discoveries in human history. Antibiotics 
are defined as a medication that inhibits the growth of or destroys microorganisms. 
Through serendipity, a Scottish bacteriologist, Alexander Fleming, left a culture of 
staphylococci uncovered in his lab and came back to discover that mold that grew there 
was attacking the bacteria. That observation marked the beginning of the penicillin 
revolution in 1925, the first antibiotic in history.1,2 Following the introduction of penicillin, 
the leading causes of death shifted from communicable diseases to non-communicable 
diseases such as heart diseases and cancer. In the United States, the average life 
expectancy rose from 47 years to 78 years during the antibiotic era.3 The percentage of 
older adults in the United States (U.S.) population increased from 4% to 13% as well.4 
Compared with other age groups, the older adult population has the highest antibiotic 
consumption rate. The antibiotic prescription rate in the U.S. decreased among children 
and adolescents from 2000 to 2010 and increased by 30% among the older adults over 
the same time period.5  
    A recent study conducted by Olesen, et al. using Medicare Part D data reported that 
19.5 million antibiotic prescriptions were claimed to Medicare beneficiaries from 2011 to 
2015.6 The prescription rate was similar over the study period, with 1364.3 claims per 
1000 beneficiaries.  Of those claims, 552 per 1000 beneficiaries were considered 
potentially inappropriate. Another nationally representative study that captured 86% of 
all ambulatory outpatient prescriptions in the U.S. reported that 51.6 million antibiotic 
prescriptions were prescribed to older adult patients in 2014.7 The rate of antibiotic 
prescribing (1115 prescriptions per 1000 persons) was lower than reported by Olesen, 
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et al.,6  but differences in the study population in terms of health insurance or patients’ 
characteristics and diseases severity might explain this discrepancy. Fleming-Dutra et 
al.,8  reported that 30% of outpatient antibiotic prescriptions among all ages were 
inappropriate in 2011. Older adults, in particular, received 617 prescriptions per 1000 
persons and 18% of those prescriptions were deemed inappropriate. Table 1.1 presents 
the recent literature that examined the antibiotic prevalence among US adults 
population. There are still limited reports describing antibiotic use and antibiotic 
appropriateness among the older adult population in the U.S., a knowledge gap that we 
are hoping to address with this research.  
 
 4 
 
Table 1.1 A summary of the recent studies that examine the antibiotics rate among the US population.  
Author  Study Settings   Study Population  Sample 
Size  
Conclusion   
Lee, Grace C., et al.  MEPS data from 
2000-2010  
US civilian, non-
institutionalized 
population 
1.4 billion 
outpatients 
records  
The antibiotic prescription rate in the 
U.S. decreased among children and 
adolescent from 2000 to 2010 and 
increased by 30% among older adults.  
Fleming-Dutra, 
Katherine E., et al. 
2010-2011 National 
Ambulatory Care 
Survey and National 
Hospital Ambulatory 
Medical Care Survey.  
US population  184,032 
sampled 
ambulatory 
care visits  
12.6% of US Ambulatory care visits 
were associated with antibiotic 
prescriptions. 18% of the antibiotic 
prescriptions were considered 
inappropriate among the older adult 
population.  
 
Kabbani, Sarah, et al. 2011-2014 of IQVIA 
Xponent database  
US older adults 
visiting the outpatient 
settings  
51.6 million 
prescriptions 
were 
dispensed in 
2014  
The rate of antibiotic prescriptions 
remains the same over the study period 
(1,115 prescriptions/1,000 persons)  
Sanchez, Guillermo 
V., et al. 
2008-2011 2010-2011 
National Ambulatory 
Care Survey 
US population 
related Macrolide 
visit  
2399 Only 5% of macrolide prescribing is 
following the guidelines which 
macrolides are a first line therapy.  
Roumie, Christianne 
L., et al. 
1995-2002 National 
Ambulatory Care 
Survey and National 
Hospital Ambulatory 
Medical Care Survey. 
US adults 18 year or 
older  
Unknown Overall antibiotic rate remains the 
same over the study period from 302.4 
in 1996 to 304.1 in 2002.  
Hicks, Lauri A., et al. 2011 IMS Health 
Xponent database  
US population  Unknown  In 2011, health care providers 
prescribed over 260 million of 
antibiotics in the outpatient setting. The 
 
 5 
overall rate of antibiotic was 842 
prescriptions per 1000 persons. Older 
adults received 1048 prescriptions per 
1000 persons, which is the highest rate 
compared to other age groups.  
Mundkur, Mallika L., 
et al. 
2006-2015 Optum 
Clinformatics 
Datamart  
US adult population  Unknown  The rate of antibiotic prescription 
decreased significantly (5%) among 
older adults from 991 to 943 
prescriptions/1000 persons over the 
study period.  
Olesen, Scott W., et 
al. 
2011-2015 Medicare 
US national 
healthcare program 
database  
US older adult 
population  
4.5 million 
Medicare 
beneficiaries  
The antibiotic use remains the same 
over the time period with 1364 
prescriptions per 1000 beneficiaries 
during the study period. 40% of the US 
Medicare beneficiaries have received 
potentially inappropriate antibiotics.  
Suda, Katie J., et al. 2006-2010 IMS Health 
Xponent  
US adult population  Unknown  Overall, 1.34 billion antibiotic 
prescriptions were dispensed from 
2006-2010. The antibiotic rate declined 
by 2.8% over the study period from 
892.21 to 867.58/1000 population.  
  
 
 6 
Antibiotic Complications:  
    Evidence shows that allergic reactions, antibiotic resistance, C. difficile infections and 
drug interactions and side effects are the most common complications associated with 
antibiotic use/overuse. Antibiotics are the second most common drug class associated 
with adverse drug events among older adults in the ambulatory setting (15%), after 
cardiovascular agents (26%), and carry double the risk associated with anticoagulant 
medications (7.9%).9  
    Antibiotic resistance is considered a global threat caused by antibiotic overuse or 
misuse. It happens when bacteria develop a way to overcome the medication that is 
intended to kill them.10 The older adult population is at higher risk of antibiotic use, 
immune system impairment and multiple chronic health conditions which could lead to 
antibiotic resistance compared to other age groups.11,12,13 The Centers for Disease 
Control and Prevention (CDC) reported that 2 million people each year are diagnosed 
with infections caused by antibiotic-resistant bacteria. In addition, 23,000 people die 
each year in the U.S. due to antibiotic resistance.10 In 2015, the U.S. White House 
released a national action plan to defeat antibiotic resistance through developing 
innovative prevention strategies, enhancing surveillance, and implementing 
antimicrobial stewardship programs.14  
    Another complication due to antibiotic use/overuse is Clostridioides difficile (C. diff) 
Infection (CDI). C. diff is a gram-positive, anaerobic bacillus that is often associated with 
severe diarrhea and abdominal cramping. The CDC estimated in a recent report that 
each year there are 500,000 CDI cases in the U.S., with 15,000 deaths attributable to 
CDI annually.15 CDI costs the U.S. health care system up to 4.8 billion each year. The 
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rate of CDI has increased dramatically in recent years, specifically among the older 
adult population. Ninety-three percent of deaths attributable to CDI occur in older adults, 
making it the 18th leading cause of death in the United States among older adults.16 
Prior antibiotic use, recent hospitalization, proton pump inhibitors use and a weakened 
immune system are risk factors of CDI in older adults.17,18,19 As with antibiotic 
resistance, the U.S. is working on a national plan to combat antibiotic resistant and 
reduce the rate by 50% by 2020. One major element of this program is antimicrobial 
stewardship programs.   
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Antibiotic Stewardship Programs (ASPs):  
    Antibiotic stewardship programs aim to improve antibiotic use and reduce the number 
of inappropriate antibiotic prescriptions, antibiotic resistance, side effects associated 
with antibiotic use, and CDI. The program should help health care providers and 
hospitals optimize antibiotic therapy. Progress in ASPs has primarily been in the acute 
care setting. Effective on January 2017, the Joint Commission approved and released 
the new antimicrobial stewardship standard, which requires all hospitals, critical access 
hospitals, nursing homes, ambulatory care organizations, and office-based surgery 
practices to implement ASP in their settings.20 As a result, during the time frame when 
we conducted our studies, it was not mandatory for health systems to have an ASP for 
outpatient settings.  
    According to the CDC, a successful ASP is based on seven key elements including 
leadership commitment, accountability, medication expertise, action, tracking, reporting 
and education.21 Table 1 shows the detail for each element.  
Table 1.2. The CDC’s essential core elements for antibiotic stewardship programs 
Key Element  Explanation  
Leadership commitment Hospitals should invest money, clinicians, IT support, nurses, and 
pharmacists to implement ASP.  
Accountability Hospitals should appoint a single leader who will be responsible for 
program outcomes.  
Medication expertise Hospital should appoint a pharmacist to lead and support the 
appropriate antibiotic prescribing.  
Action Hospitals should design a systematic approach to evaluate 
patient’s needs for antibiotic.  
Tracking Hospitals are responsible to track antibiotic prescriptions and 
antibiotic resistance.  
Reporting Hospitals should report the trend and the patterns of the negative 
outcomes related to antibiotic misuse.  
Education Hospitals should offer educational sessions to all health care 
providers regarding antibiotic use, side effect, resistance, and CDI. 
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       Although many studies support the necessity of ASPs, other studies have shown 
little effect from implementing ASPs. The success of ASPs may depend on including all 
of the seven elements that we have mentioned in Table 1. ASPs have been projected to 
mitigate 619,000 infections associated with antibiotic resistance.22  In addition, it is been 
estimated that implementing ASPs in acute care would save approximately $7.7 billion 
in direct medical costs. Although ASPs have been implemented in acute care for 30 
years or more, they are still not required in most other health care settings including 
outpatient settings where most older patients receive care.  The Centers for Medicare & 
Medicaid Services (CMS) announced that by November 2019, most long term care 
settings (nursing homes) will be required to implement ASPs. 
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The Older Adult Population:  
    Older adult is a term referring to a person who is 65 years or older. Today, there are 
almost 40 million persons aged 65 years and older living in the U.S., and this number is 
expected to increase to 89 million persons in the next 30 years.23 This rapid change in 
population characteristics can lead to economic, social, and health care consequences, 
especially if the healthcare system does not prepare for this change. Many older adults 
have multiple comorbidities and receive more than one prescription medication, which 
may lead to difficulty in managing their health and maintaining their quality of life. Also, 
older adults experience physiologic changes associated with aging affecting their liver 
and kidney function and immune system which may necessitate more individualized 
dosing adjustment for antibiotics compared to other age groups.24 
 
Figure 1.1. U.S. Population Ages 65 and Older, 1950 to 2050.25  
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   Human beings experience normal changes during the aging process and these 
changes are categorized as biological, psychological, and sociological. The most critical 
changes contributing to an increased risk of infection in older age are the physiological 
changes in the immune system. It is well established that the immune system response 
to pathogens declines with age. In nonspecific immunity, the number of leukocytes 
decreases with age. In humoral immunity, the level of isoagglutinins in the blood 
declines in the older population. Also, the antibody response to the influenza vaccine 
decreases in the older population. Moreover, as we age the capacity for mounting a 
cell-mediated immune response declines.25 In addition, there are several biological 
changes responsible for increasing the chance of infections in older adults including 
changes in skin and mucosal barriers as a first line defense in the immune system. 
During the aging process, skin becomes thinner and skin elasticity is weaker. Some 
observations showed that the atrophy and drying of the skin were responsible for 
endocarditis.26 Also, blood flow to the skin decreases as we age, which increases the 
likelihood of chronic pressure ulcers. The rate of urinary tract infections (UTIs) is higher 
among older adults. The biological changes in the excretion system may play an 
essential role including decreased plasma flow through the kidney by 50% and 
decreased glomerular filtration rate by 30%, which likely contribute to the development 
of UTIs. Another physiological change as we age is the weakness of the muscles 
around the bladder, consequently the bladder accumulates urine and emptying the 
bladder becomes more difficult, which increases the risk of a urinary tract infection. 
Older adults are at higher risk of using urinary catheters, especially in long-term care 
facilities and this may also increase the risk of urinary tract infections in both genders. 
 
 12 
Most nursing home residents are at higher risk of infections especially UTI and URI due 
to frailty, intubation, catheterization, physical dependence, cognitive impairment and 
altered host resistance.27 However, the diagnosis of infection in older adult patients is 
not always obvious and simple. The symptoms of infections in the older patient is 
different than a younger patient and may not include fever that most of the health care 
providers rely on to make a clinical decision of infection.11 This is because of the 
physiological changes in temperature regulation due to normal aging.28 It is expected 
that older adult patients  present with infection without having a fever as well.28 On the 
other hand, taking patient history is an important element for an accurate diagnosis. 
This is an issue with cognitively impaired patients. In addition, the symptom of delirium 
may have many underlying causes including UTI which makes it difficult for the 
physician to reach on accurate diagnosis.29,13 Physicians should be careful when 
initiating an antibiotic prescription to an older adult patient. 
    These physiological changes that occur during aging are not only contributing to an 
increased risk of infection, they also affect the response to antibiotics. As part of normal 
physiological changes as we age, several organ functions important for eliminating 
antibiotics from the body, including kidney function and liver function, decline.30 Altered 
drug elimination may necessitate lower doses of antibiotics in older adults to avoid 
undesirable side effects or lower rate of clinical outcomes from the antibiotic.   
    Another common issues regarding antibiotic use among older adult population are 
adverse drug reactions and drug-drug interactions. Previous studies have demonstrated 
a positive relationship between adverse drug reactions and increasing age.31 It has 
been reported to increase the odds of hospital admission and health care cost.31 The 
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common reported adverse drug reactions among older adults are anaphylaxis or allergic 
reaction, Q-T prolongation, nephrotoxicity, and ototoxicity.32 On the other hand, older 
adult patients at increased risk of drug-drug interactions due to polypharmacy, 
comorbidities, and altered physiological functions due to aging.33        
  
Geriatrics Clinic and Adult Internal Medicine Ambulatory Clinic at VCU Health:  
    The Geriatrics clinic (GC) at VCU Health, under the internal medicine clinics 
structure, has been active for more than 30 years when it was founded by Dr. Peter 
Boling. Dr. Boling had the passion and initiative to establish the GC to provide 
specialized care to complex and vulnerable older adult patients. Due to an increase in 
the number of complex patients being cared for at VCU Health, the Geriatrics clinic 
became a separate clinic from the Adult Internal Medicine Clinic starting in January 
2012. All of the physicians serving the patients in the GC are geriatricians, and the 
nurse practitioners are either adult-gerontology or family medicine specialists. The 
overall goal of the GC is to provide comprehensive care for older adults (65 years or 
older) who have complex needs like polypharmacy and multiple chronic conditions. In 
comparison with older adult patients visiting the Adult Internal Medicine clinic, the GC 
patients are considered sicker and more complex patients regarding medications and 
the number of medical conditions according to Martha Purvis, an experienced nurse 
practitioner at the GC. A recent statistic shows that the GC provides care to over 500 
patients per provider annually.  
    On the other hand, the Adult Internal Medicine clinic has been providing care for older 
adult patients at VCU Health since 1838. The Department of Internal Medicine at VCU 
Health consists of more than 180 clinicians, 124 residents under training, and over 80 
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fellows. There are ten divisions under the department of internal medicine, which 
includes Cardiology, Endocrinology, Gastroenterology, General Internal Medicine, 
Geriatrics, Hematology, Infectious Diseases, Nephrology, Pulmonary diseases, and 
Rheumatology.  
    In one of the studies presented in this dissertation (Study Two), we used data from 
2012-2017 from the Geriatrics clinic, and the Adult Internal Medicine clinic. 
Antibiotic Appropriateness:  
    Antibiotic inappropriateness could lead to increased risk of antibiotic resistance, C.diff 
infection and preventable adverse drug reactions. Antibiotic inappropriate is defined as 
“Use of antimicrobials in the setting of established infection to which the pathogen is 
resistant or use of antimicrobials not recommended in treatment guidelines.”34 There are 
different definitions of assessing antibiotic appropriateness in epidemiological studies. 
Most of them have used subjective measures based on expert opinion-based 
definitions. These opinions are usually based on treatment guidelines for specific 
infections, dosage adjustment, medication route, or duration of therapy. In our studies, 
we have used a validated method developed by Fleming-Dutra et al.8 This study used a 
comprehensive methodology with a team of experts systematically reviewing the 
national guidelines for antibiotic use for common infectious diseases among the older 
adult population. The criteria for antibiotic appropriateness that we have used in our 
studies was based on diagnoses and treatment guidelines. This method was 
appropriate for our studies due to availability of the variables that we need to assess 
antibiotic appropriateness. For instance, we lack the medication dose, or duration of 
therapy variables, that is why we didn’t evaluate the appropriateness based on either 
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dose or duration of therapy. Despite the limitation of our method, expert opinion-based 
evaluations are commonly used in epidemiological studies.         
  
 
 16 
Rational (Significance):  
    A nationally representative study in the U.S. demonstrated significant increases in 
broad-spectrum antibiotic use among the older adult population from 2000 to 2010.5 In 
2000, the antibiotic use was about 287 prescriptions per 1,000 persons, and this 
number doubled by 2010 to 482 prescriptions per 1,000 persons. The most commonly 
prescribed antibiotics vary and depend on the guidelines of the treatment in specific 
countries. For instance, in the U.S. and Canada, quinolones were the most commonly 
prescribed antibiotics for urinary tract infections (UTI),35,36 while in Australia, doxycycline 
was the most widely prescribed antibiotic for UTI and respiratory infections.37 The term 
“older adult” that was used in these studies referred to a person who was 65 years or 
older. Today, there are almost 40 million persons aged 65 years and older living in the 
U.S., and this number is expected to increase to 89 million persons in the next 40 
years.38 This rapid change in population characteristics can lead to economic, social, 
and health care consequences, especially if the healthcare system does not prepare for 
this change.  
 
    The two major threats of antibiotic overprescribing are antibiotic resistance and 
increased CDI incidence rate. These threats have received significant focus at the 
international level from organizations like the World Health Organization (WHO) and at 
the national level in the U.S. from organizations like the White House initiative to combat 
antibiotic resistance.39 As a result of our studies, we seek to add valuable information to 
the literature in order to better understand antibiotic use among the older adult 
population. This information is currently limited in the literature, and comparing our 
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results with the previous studies within the same scope would be helpful to understand 
antibiotic use among older adults. There is limited information regarding this issue within 
the older adult population due to lack of accessible data to facilitate this kind of study. 
We are aiming that the results of our studies will help to uncover needs that might be 
addressed through antibiotic stewardship programs and the consequences of antibiotic 
misuse among older adults.  
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Specific Aims:  
    This dissertation project is comprised of three different studies that are related to 
antibiotic use among the older adult population using national and local data sources. 
The objectives of each study are listed below.  
 
Study 1: The Trend of Antibiotic Use Among Community-Dwelling Older Adults in 
The United States (Medical Expenditure Panel Survey MEPS 2011-2015). 
The specific aims are:  
1) To understand the patterns of antibiotic use among non-institutionalized 
community-dwelling older adults using Medical Expenditure Panel Survey MEPS 
from 2011-2015. 
2) To describe the patterns of the most common infectious diseases among non-
institutionalized community-dwelling older adults using Medical Expenditure 
Panel Survey MEPS from 2011-2015. 
3) To understand the association between antibiotic use and demographic, 
socioeconomic characteristics and emergency department visits. 
 
Study 2: A Comparison of Antibiotic Use and Infectious Diseases Among Older 
Adults between Geriatrics Clinic and Adult Internal Medicine Ambulatory Care 
Clinic in VCU Health.   
The specific aims are:  
1. To assess the trend of antibiotic use and infectious diseases among Geriatrics 
clinic patients at VCU Health from 2012-2017.  
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 1A) To assess the most common antibiotics prescribed for the three most 
common infectious diseases: urinary tract infection (UTI), upper respiratory tract 
infection (URI), and skin infection.  
2. To assess the trend of antibiotic use and infectious diseases among older adult 
patients visiting adult internal medicine ambulatory care clinic at VCU Health 
from 2012-2017. 
2A) To assess the most common antibiotics prescribed for the three most 
common infectious diseases: urinary tract infection (UTI), upper 
respiratory tract infection (URI), and skin infection.  
3. To compare the antibiotic appropriateness between the Geriatrics clinic and Adult 
Internal Medicine Ambulatory clinic at VCU Health from 2012-2017. 
4. To assess the relationship between the antibiotic appropriateness and 
demographic, socio-demographic characteristics, type of clinic, antibiotic 
negative outcomes like emergency department visit or hospitalization within 30 
days after the initiation of antibiotics. 
 
Study 3: Antibiotic Use Among Older Adults Visiting The Emergency Department 
(ED) at VCU Health 2012-2017. 
The specific aims are:  
1. To assess the trend of antibiotic use and infectious diseases among older adult 
patients (65 years or older) visiting the ED at VCU Health from 2012-2017.  
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 1A) To assess the most common antibiotics prescribed for the three most 
common infectious diseases: urinary tract infection (UTI), upper respiratory tract 
infection (URI), and skin infection.  
2. To assess the trend of antibiotic use and infectious diseases among middle-aged 
patients (55 to 64 years old) visiting the ED at VCU Health from 2012-2017. 
2A) To assess the most common antibiotics prescribed for the three most 
common infectious diseases: urinary tract infection (UTI), upper 
respiratory tract infection (URI), and skin infection.  
3. To compare the antibiotic appropriateness between older adult patients and 
middle-aged patients visiting the ED at VCU Health from 2012-2017. 
4. To assess the relationship between antibiotic appropriateness and demographic, 
socio-demographic characteristics, age group, antibiotic negative outcomes like 
ED visit or hospitalization within 30 days after the initiation of antibiotics. 
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Summary:  
    This dissertation contains five chapters. The first chapter is the introductory chapter, 
which provides an overview of antibiotic use, and its complications among older adults. 
In addition, the first chapter describes the aging population in the U.S. and the rational 
and specific aims for each study. The second chapter details the first study, which aims 
to answer questions related to antibiotic use among non-institutionalized older adults in 
the U.S. using nationally representative data. The third chapter describes a study 
examining the issue of antibiotic appropriateness and compares the patterns of 
antibiotic use and infectious diseases between Geriatrics clinic patients vs. adult 
Internal Medicine Ambulatory clinic at VCU Health from 2012-2017. The fourth chapter 
describes the results of the final study, which examined antibiotic appropriateness 
among older adults visiting the ED at VCU Health from 2012-2017. The final chapter is 
the discussion chapter, which describes the main findings, draws overarching 
conclusions and discussed the implications of the work and future directions.      
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CHAPTER TWO 
 
Study 1: The Trend of Antibiotic Use Among Community-Dwelling Older Adults in 
The United States (Medical Expenditure Panel Survey MEPS 2011-2015) 
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Background:  
It has been well documented that antibiotic overuse/misuse increases the risk of 
Clostridioides difficile (C.diff) infection as well as antibiotic resistance.1,2 The Centers for 
Disease Control and Prevention (CDC) has reported that 23,000 people die each year 
due to antibiotic resistant infections.2 Older adult populations are growing globally and in 
the United State (US) specifically. It was estimated that the adult population aged 65 or 
older will grow to around 89 million people by 2050 in the US, more than double the 
number of older adults in 2010.3 This specific population has unique characteristics that 
need more attention in terms of health care improvement. Older adult patients are more 
likely to have comorbidities, polypharmacy, and changes in kidney and liver function 
that could affect the pharmacokinetics and other responses to antibiotics.4,5  
Antibiotic overuse leads to significant increase in the emergency department 
visits associated with adverse drug reactions.6 Older adults aged 65 and older are at 
increased risk of adverse outcomes from antibiotics and other drug classes like 
anticoagulants and antidiabetic medications.7 Despite the extensive efforts from the 
CDC, US government, and the health care system to reduce antibiotic prescribing 
through implementing antimicrobial stewardship programs8 among all ages, antibiotic 
prescription rates increased 30% among older adults from 2000 to 2010, while the 
antibiotics rate decreased among children and adolescents.9   
In addition, it is important to understand prescribing practices among older adults 
from a nationally representative perspective to inform health care initiatives to improve 
antibiotic use and reduce the negative outcomes related to antibiotic misuse like allergic 
reactions, drug-drug interactions, and C.diff infections. Therefore, the first objective of 
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this study was to understand the patterns of antibiotic use among community-dwelling 
older adults in the US using the Medical Expenditure Panel Survey (MEPS), a nationally 
representative database from 2011-2015. The second objective was to document the 
most common infectious diseases in the same population. The third objective was to 
understand the association between antibiotic use and demographic characteristics, 
socioeconomic characteristics and emergency department utilization.           
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Methods:  
Data Source:  
A cross-sectional retrospective study was conducted to assess the patterns of 
antibiotic use among community-dwelling older adults using MEPS 2011-2015. The 
most recent MEPS database available was used in this study. MEPS is collected by the 
Agency for Healthcare Research and Quality (AHRQ).10 MEPS is a publicly available 
nationally representative database that surveys non-institutional families and 
individuals, and their medical providers across the US. The data includes only de-
identified patient characteristics and pharmacy claims. MEPS uses a complex stratified 
multistage cluster design technique during the survey collection, which allows 
researchers to calculate national weighted estimates. In addition, all the information in 
the patient full-year consolidated data files, medical conditions files, prescribed 
medicine files, and emergency room files were used in the analysis.  
Study Sample:  
Only individuals 65 years and older were included in this analysis. From the full-
year consolidated file, we obtained age, gender, race, marital status, level of education, 
health status, flu vaccination status, annual family income, and health insurance status. 
We collected antibiotic prescriptions dispensed and prescribed proton pump inhibitor 
use from the prescriptions file. In MEPS data, participants reported the list of 
medications and were asked for permission to look at their pharmacy data as well. From 
the emergency file, we obtained the number of ER visits in the past 30 days. Infectious 
disease diagnoses were obtained from the medical conditions file and identified using 
the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-
 
 31 
CM). Upper respiratory tract infections (URI) were included using the following ICD-9-
Codes: 041, 460, 461, 462, 463, 464, 465, 466, 486, and 490. ICD-9-Code 599 was 
used for urinary tract infection (UTI). Skin and soft tissue infections were included using 
ICD-9-Codes 681, 682, 686, 690, 691, and 691. ICD-9-Codes 008 and 009 were used 
to define any intestinal infections, while 486 was used to define pneumonia cases. Any 
participants younger than 65 years of age or with incomplete information regarding 
antibiotic use were excluded. 
Statistical Analysis:  
Descriptive analysis was used to calculate the weighted frequency and 
percentage for the categorical variables in both antibiotic users and non-users. A chi-
square test was used to test the association between the covariates and the outcome of 
interest (antibiotic use). Trend analysis was performed using the Cochran–Armitage 
test. U.S. Census data were used to calculate the rate of infectious diseases and 
antibiotic prescriptions per 10,000 population.11 A multiple logistic regression model was 
used to test the association between antibiotic use and demographic characteristics, 
geographic region, socioeconomic characteristics and emergency department use. Any 
variable that maintained a p-value of 0.1 was included in the multiple logistic regression 
model. We have used the MEPS person weights, sampling variance estimation strata 
for each year in order to calculate a nationally weighted estimate. A p-value less than 
0.05 was considered statistically significant. All the statistical analyses were conducted 
using SAS software version 9.4 (SAS Institute, Inc., Cary, NC).  
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Ethical Considerations:  
This study was deemed as an exempt study by the Virginia Commonwealth 
University Institutional Review Board (VCU IRB #HM20013520).        
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Results:  
In our study, there were 105,762,134 prescriptions dispensed to older adults in 
the outpatient settings in the US from 2011 to 2015. The overall rate of antibiotic 
prescriptions dispensed increased slightly, from 484 prescriptions per 1,000 persons in 
2011 to 540 prescriptions per 1,000 persons in 2015. Prescribing rates decreased with 
age, the oldest-old participants (80 years or older) reported lower prescriptions than 65-
69 year olds, 7% and 11% respectively (Table 2.1).  Antibiotic prescriptions were more 
common among women (18%) compared to men (12%). White participants received 
more antibiotics (27%) than African Americans (1.77%) and others (1.4%). Eight 
percent of older adults who received antibiotic prescriptions reported that they visited 
the emergency department at least once in the study period (2011-2015).  
Multiple logistic regression modeling shows that the 75-79 years age group are 
41% more likely to receive antibiotics compared to the oldest-old group (80 or older) 
(Table 2.2). Females were significantly (52%) more likely to receive antibiotics 
compared to men. Moreover, ER visits were significantly associated with antibiotic 
prescriptions; older adults visiting the ER were two times more likely to receive and 
antibiotic compared to non-ER visitors. Proton-pump inhibitors PPI users were not 
associated with antibiotic dispensing compared to non-antibiotic users.   
URI, UTI, and skin infections were the most common infectious diseases 
documented in our study population. The rate of URI increased over time from 135 
infections per 1,000 persons in 2011 to 166 infections per 1,000 persons in 2015 
(Figure 2.1). The same trend was observed in UTI infections which increased from 55 to 
75 infections per 1,000 persons between 2011 and 2015. Macrolides, quinolones, and 
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penicillins were the most common antibiotic categories prescribed to older adults from 
2011 to 2015. The rate of use of penicillins increased over the study period from 169 
prescriptions per 1,000 prescriptions to 256 prescriptions per 1,000 prescriptions, 
accounting for 21% of all antibiotic prescriptions. Quinolone prescription rates were 
stable while macrolide prescription rates dropped from 334 to 156 prescriptions per 
1,000 prescriptions, accounting for 26% of all antibiotic prescriptions (Figure 2.2).         
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 Table 2.1. The demographic characteristics of antibiotic users and non-users in MEPS from 
2011-2015. 
Variable  Antibiotic Use (Yes) 
Sample 
persons       Weighted %, [95% CI] 
Antibiotic Use (No) 
Sample 
persons     Weighted %, [95% CI] 
Age (years) 
65-69 
70-47 
75-79 
80 or older 
 
1844 
1182 
891 
1110 
 
10.59 [9.77- 11.40] 
7.40 [6.88-7.91] 
5.60 [5.10-6.09] 
6.99 [6.31-7.67] 
 
4286  
3053 
2317 
3438 
 
       21.78 [20.80-22.77] 
       16.38 [15.51-17.26] 
       12.41 [11.64-13.18] 
       18.82 [17.59-20.05] 
Sex  
Male 
Female 
 
1927 
3100 
 
12.17 [11.50-12.85] 
18.41 [17.64-19.17] 
 
5829 
7265 
 
      31.98 [30.96-33.00] 
      37.42 [36.45-38.38] 
Race  
White 
African American 
Other  
 
3996 
658 
373 
 
27.41 [26-24-28.58] 
1.77 [1.51-2.02] 
1.40 [1.09-1.71] 
 
9004 
2730 
1360 
 
      58.00 [56.55-59.45] 
      6.90 [6.00-7.80] 
      4.49 [3.44-5.53] 
Marital status  
Married 
Other 
 
2598 
2429 
 
17.31 [16.27-18.34] 
13.27 [12.52-14.02] 
 
6541 
6553 
 
      37.88 [36.45-39.30] 
      31.53 [30.04-33.01] 
Education  
No education 
High school or less 
College years 
 
12 
1148 
617 
 
0.13 [0.01-0.25] 
19.26 [17.66-20.86] 
11.85 [10.69-13.01] 
 
40 
2997 
1589 
 
      0.28 [0.14-0.41] 
     40.86 [38.99-42.74] 
     27.59 [25.62-29.57] 
Health status  
Excellent 
Very good 
Good or fair 
Poor 
 
649 
1380 
2585 
347 
 
4.79 [4.31-5.27] 
9.04 [8.41-9.67] 
14.90 [14.06-15.74] 
1.87 1.60-2.13] 
 
1778 
3563 
6797 
770 
 
     11.16 [10.37-11.95] 
     21.48 [20.67-22.30] 
     33.26 32.21-34.30] 
     3.46 [3.09-3.84] 
Flu vaccine 
Yes 
No 
 
890 
242 
 
24.20 [22.28-26.11] 
6.15 [5.09-7.20] 
 
2214 
858 
 
     51.13 [48.58-53.68] 
     18.51 [16.72-20.30] 
Family income  
Poor or near poor 
Low income  
Middle income 
High income 
 
1411 
1268 
1071 
1180 
 
6.85 [6.28-7.43] 
7.67 [7.10-8.24] 
7.19 [6.59-7.79] 
8.94 [8.12-9.76] 
 
4084 
3381 
2767 
2513 
 
     17.25 [16.20-18.30] 
     18.56 [17.53-19.60] 
     16.35 [15.40-17.30] 
     17.14 [15.82-18.46] 
Insurance  
Private  
Medicaid  
Medicare 
 
1740 
3207 
26 
 
12.11 [11.26-12.97] 
18.49 [17.63-19.36] 
0.06 [0.03-0.10] 
 
3848 
8914 
103 
 
     25.09 [23.92-26.26] 
     43.89 [42.64-45.14] 
     0.32 [0.17-0.48] 
ER visit  
No visit  
1 to 3 visits 
4 or more visits 
 
3555 
1389 
83 
 
21.97 [21.09-22.85] 
8.18 [7.61-8.75] 
0.43 [0.32-0.53] 
 
10800 
2225 
69 
 
     57.55 [56.47-58.63] 
     11.48 [10.81-12.15] 
     0.36 [0.24-0.49] 
PPI prescribed 
Yes 
No 
 
1285 
3742 
 
7.77 [7.16-8.39] 
22.80 [21.91-23.70] 
 
2629 
10465 
 
     13.67 [12.86-14.47] 
     55.74 [54.57-56.91] 
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Table 2.2. Multiple logistic regression analysis predicting antibiotic users vs. non-users 
Variable  Unadjusted or [95% CI] Adjusted or [95% CI] 
Age (years) 
80 or older 
65-69  
70-47  
75-79  
 
1 [Reference]  
1.30 [1.13-1.50] * 
1.21 [1.07-1.38] * 
1.21 [1.04-1.40] * 
 
1 [Reference] 
1.19 [0.66-2.13] 
1.36 [0.80-2.29] 
1.41 [0.81-2.44] 
Sex  
Male 
Female 
 
1 [Reference] 
1.29 [1.18-1.40]* 
 
1 [Reference] 
1.52 [1.10-2.10] * 
Race  
White 
African American 
Other   
 
1 [Reference] 
0.54 [0.47-0.62] * 
0.66 [0.54-0.79] * 
 
1 [Reference] 
0.69 [0.43-1.10] 
1.20 [0.70-2.08] 
Marital status  
Other 
Married 
 
1 [Reference] 
1.08 [0.98-1.19] 
 
1 [Reference] 
1.17 [0.86-1.59] 
Education 
College years 
No education 
High school or less 
 
1 [Reference] 
1.10[0.41-2.95] 
1.09[0.95-1.26] 
 
1 [Reference] 
0.73 [0.26-2.01] 
1.43 [1.00-2.04] * 
Health status  
Good or fair 
Excellent 
Very good 
Poor 
 
1 [Reference] 
0.95 [0.84-1.09] 
0.93 [0.85-1.03] 
1.20 [0.99-1.46] 
 
1 [Reference] 
0.96[0.53-1.76] 
0.93 [0.66-1.32] 
1.23[0.72-2.09] 
Flu vaccine  
No 
Yes 
 
1 [Reference] 
1.42 [1.15-1.75] * 
 
1 [Reference] 
1.12 [0.79-1.59] 
Family income  
High income  
Poor or near poor 
Low income  
Middle income 
 
1 [Reference] 
0.76 [0.68-0.85] * 
0.79 [0.70-0.88] * 
0.84 [0.74-0.95] * 
 
1 [Reference] 
0.49 [0.29-0.84] * 
0.60 [0.37-0.98] * 
0.54 [0.33-0.89] * 
Insurance  
Medicare 
Private  
Medicaid  
 
1 [Reference] 
1.14[1.04-1.25] * 
0.50[0.28-0.90] * 
 
1 [Reference] 
1.09 [0.77-1.55] 
1.01[0.27-3.80] 
ER visit 
No Visit 
1 to 3 visits 
4 or more visits 
 
1 [Reference] 
1.86 [1.69-2.05] * 
3.06 [2.02-4.63] * 
 
1 [Reference] 
2.03 [1.42-2.89] * 
0.08 [0.00-1.04] 
PPI prescribed 
No 
Yes 
 
1 [Reference] 
1.39 [1.26-1.53] * 
 
1 [Reference] 
1.10 [0.76-1.58] 
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Figure 2.1. The trend of infectious diseases among older adults using MEPS 2011-
2015.  
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Figure 2.2. The rate of antibiotic prescriptions per 1000 prescriptions among older 
adults using MEPS 2011-2015. 
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Discussion:  
This study assessed the prevalence of antibiotic prescriptions dispensed among 
community-dwelling older adults in the US using MEPS 2011-2015 data. In addition, this 
study assessed the rate of infectious diseases and the predictors of antibiotic users 
compared to non-users. Several studies have reported the rate antibiotic use in different 
time periods, age groups, and data sources, but this study specifically focused on the 
older adult population. Older adults are at high risk of polypharmacy, drug-drug 
interactions, adverse drug reactions, comorbidities as well as age-associated 
physiological and changes that affect the pharmacokinetics and pharmacodynamics of 
medications.  Antibiotic use in this population has rarely been reported in the literature 
and antibiotic prescribing practices are not clear. Based on our results, 31% of the non-
institutional older adults in the US were prescribed antibiotics, accounting for 
105,762,134 prescriptions over the study period. We estimate that the antibiotic 
prescribing rate increased slightly from 483 to 540 prescriptions per 1,000 persons. A 
similar rate was observed in 2010 by Lee et al., using the early rounds of MEPS data 
suggesting that the rate has been relatively stable since 2010.9 This unchanged rate 
since 2010 could be explained by several reasons. First, the effort of implementing 
antibiotic stewardship programs (ASPs) is not strong enough to cover a wide range of 
settings in the health care system, like ambulatory care clinics, assisted living facilities, 
and pharmacies. A study estimated that 30% of outpatient antibiotics were inappropriate 
among all ages.12 Therefore it is crucial to implement ASPs in outpatient settings in 
addition to inpatient settings. Second, there could be a lack of knowledge among some 
health care providers about ASPs instituted by institutions where they practice. A study 
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found that 25% of nurses at VCU-HS were not aware that ASPs existed at VCU 
Health.13 Education is also important to family members who have a significant impact 
on antibiotic prescribing among older adult populations.14,15,16  
We have found that in 2015, the antibiotic prescribing rate was 540 prescriptions 
per 1,000 persons, and this estimate is lower than the rate of antibiotic prescribing 
reported in a study conducted by Olesen et al., using data from Medicare beneficiaries 
enrolled Medicare Part D.17 They found that the rate of antibiotic prescriptions in 2015 
was 1,364.3 per 1,000 persons. This difference could be related to the differences in the 
data sources. MEPS does not include nursing home patients or any institutionalized 
patients, unlike Medicare Part D data. We found that older adults aged 65-69 years 
were more likely to be prescribed an antibiotic than the oldest-old participants. This 
observation could be related to increasing complexity with age resulting in health care 
providers avoiding adding extra medications that could lead to an emergency visit or 
hospitalization. Evaluating the antibiotic appropriateness among older adult populations 
is necessary for future research.       
In addition, this study found that URI was on the most common infectious 
disease among older adults followed by urinary tract infections and skin and soft tissue 
infections. The rate for these diseases was relatively stable from 2011-2015. Similar 
results were found by Tan et al., when they conducted a similar study among older 
adults in Canada using The Ontario Drug Benefit Program database.18 Although the two 
databases could be different in nature, the population of older adults studied shared 
common characteristics. 
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Macrolides, quinolones, and penicillins were the most common antibiotic classes 
dispensed to older adults in the US from 2011-2015. In the Olesen et al. study, 
quinolones were most commonly prescribed, followed by macrolides and penicillins.17 In 
our study, we had a higher rate of URI treated by macrolides than rates observed in the 
other study. We observed that macrolide prescriptions deceased since 2013, while the 
rate of penicillins increased over the study period. This could be due to shifting practice 
from prescribing macrolides to pencillins due to reports of cases of severe toxicity and 
death related to macrolide use.19  
This study has several limitations. First, although we have used nationally 
representative data, using MEPS specifically could raise a selection bias limitation. 
MEPS uses self-reported surveys among active members of the society which leads to 
selection bias. Also, using MEPS data could underestimate capturing the acute 
diseases like infectious diseases. Second, in order to assess the rate of infectious 
diseases, we used ICD-9-Codes for the primary diagnosis of each participant. This 
method could underestimate the antibiotic rate because not all antibiotic prescriptions 
were prescribed for the primary diagnosis. Third, some of the variables including 
emergency department visits, health status, and annual income were obtained through 
a survey methodology which is subject to potential recall bias. Fourth, in our analysis for 
the antibiotic indications, we have used ICD-9-Codes for the entire study period, while 
ICD-10-Codes came into use in mid-2015, so there a potential that we have 
underestimated some of the indications in 2015.  
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Conclusions:  
In conclusion, the rate of antibiotic use overall remains unchanged despite 
antimicrobial stewardship efforts. The changes in the patterns of use in some of the 
antibiotic categories appear to be driven more by safety concerns rather than reducing 
overall use. Future research is needed to strengthen antibiotic stewardship programs for 
older adults in outpatient settings.  
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CHAPTER THREE 
 
Study 2: A Comparison of Antibiotic Use and Infectious Diseases Among Older 
Adult Patients of VCU Health’s Geriatrics and Internal Medicine Ambulatory Care 
Clinics    
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Background:  
Antibiotic resistance is a global threat following antibiotic use.1,2,3,4 Several 
reports have documented that the mortality rate due to antibiotic resistant infections is 
projected to reach 10 million per year by the year 2050 with an estimated health care 
cost burden of 100 trillion dollars per year by 2050.1 Studies suggest that antibiotic 
overprescribing and misuse increases antibiotic resistance and Clostridioides difficile 
(C.diff) infection. 51.6 million prescriptions (1,115 prescriptions/1,000 persons) were 
written in 2014 for older adult outpatients in the United States according to a recent 
report.5 A nationally representative study demonstrated significant increases in broad-
spectrum antibiotic use among the older adult population from 2000 to 2010. In 2000, 
antibiotic use was about 287 prescriptions per 1,000 persons, and this number doubled 
by 2010 to 482 prescriptions per 1,000 persons. In the same study, the rate of antibiotic 
prescriptions decreased from 2000-2010 among children and adolescence and 
increased about 30% among older adults.6  
The older adult population in the United States is projected to increase by 20% by 
2030 according to a recent Centers for Disease Control and Prevention (CDC) report.7 
This population is more prone to use antibiotic medications than any other age group 
due to decreased immune function, use of urinary catheters, ventilation during 
hospitalization and other factors.8,9,10 In 2010 study, older adults reported the highest 
antibiotic use rate compare to younger adults in the US.11 In addition, older adults are 
more susceptible to adverse drug reactions including C.diff infections and drug-drug 
interaction due to polypharmacy, comorbidities, and normal physiological changes like 
changes in the liver and kidney functions.12,13,14 In 2015, The White House published 
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the National Action Plan For Combating Antibiotic-Resistant Bacteria, which aspires to 
achieve a major reduction in C.diff infections and Methicillin-Resistant Staphylococcus 
aureus (MRSA) infections by 2020 by reducing inappropriate antibiotic prescriptions by 
50%.3 It is crucial to understand antibiotic use patterns in different settings in the 
healthcare system and among the older adult population in particular in order to meet 
the White House goals.  
The Geriatrics clinic at Virginia Commonwealth University (VCU) Health was 
established to support the specific care needs of older adults in the outpatient setting, 
but the pattern of antibiotic prescribing in this clinic compared to an adult Internal 
Medicine clinic serving adults of all ages at VCU Health is unknown. Therefore, the 
specific aims for this study were to:  
1. Assess the trends of infectious diseases and antibiotic prescribing among 
Geriatrics clinic patients at VCU Health from 2012-2017.  
2. Assess the trends of infectious diseases and antibiotic prescribing among older 
adult patients visiting adult Internal Medicine ambulatory care clinic at VCU Health 
from 2012-2017. 
3. Compare the antibiotic appropriateness between the Geriatrics clinic and the adult 
Internal Medicine ambulatory care clinic at VCU Health from 2012-2017. 
4. Assess the relationship between the antibiotic appropriateness and socio-
demographic characteristics, type of clinic and negative outcomes associated with 
antibiotic use including an emergency department visit hospitalization during the 
30 days after the initiation of antibiotics.  
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Methods:  
Data Source:  
We used electronic medical records data from the VCU Health Ambulatory Care 
Center (ACC) for the geriatric clinic and the internal medicine clinic from 2012-2017. 
The 2012 year was selected to start data collection because this was the founding year 
for the geriatric clinic at VCU Health. The year 2017 was the most recent complete data 
available at the time of data retrieval.  VCU Health is an urban academic medical center 
in central Virginia. The data was retrieved from the electronic medical records and 
billing records by the Bioinformatics core of the VCU Center for Clinical and 
Translational Research (CCTR). 
Study Design and Sample Selection: 
This is a cross-sectional retrospective cohort study of electronic medical records 
of Geriatrics clinic and adult Internal Medicine ambulatory care clinic from 2012-2017.  
Inclusion and Exclusion Criteria:  
Only patients 65 years or older who received an antibiotic prescription during an 
outpatient visit to either the Geriatrics clinic or adult Internal Medicine clinic at VCU 
Health from 2012-2017 were included in this study. Only oral antibiotic prescriptions 
were included in the study to avoid any inpatient antibiotic prescriptions. All patients 
who received an antibiotic prescription within 2 days of hospital discharge were 
excluded from the study to avoid any hospital related infections. All patients who 
received an antibiotic prescription that was not prescribed on the day of clinic visit were 
excluded from the study. Finally, any patient with missing information in the medication 
file or diagnosis file were excluded from the study.  
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Study Measures:  
Demographic Characteristics:  
Age, race, gender, marital status, and clinic visited were collected from VCU 
Health electronic medical records from 2012-2017. Age was treated as categorical 
variable in this study and categorized into 5 year intervals for the analysis (65-69, 70-74, 
75-79, and 80 years and older). Patients older than 80 years were censored in the 
oldest group to preserve patient confidentiality as required for an exempt study with the 
VCU Institutional Review Board (IRB).  The race variable was categorized as White, 
African American, and other. The ‘other’ category in the race variable includes American 
Indian/Alaskan, Asian, Native Hawaiian, and other. The gender variable was 
categorized as male or female. Marital status was categorized as married, single, or 
other (divorced, separated, or widowed). Type of clinic was a dichotomous variable 
defined as Internal Medicine or Geriatrics clinic.  
Outcomes Measures:  
Infectious Disease Diagnoses:  
The infectious disease diagnoses were identified by the International 
Classification of Diseases ICD-9-CM code assigned to each patient during the 
outpatient visit. VCU Health shifted to ICD-10-CM codes by end of 2015, so in our 
analysis, we have used both ICD-9-CM and ICD-10-CM codes. In our study, we 
included the most common infectious diseases among older adult patients visiting VCU 
Health outpatient clinics, which included urinary tract infection, upper respiratory tract 
infection, skin infection, pneumonia, C. diff. infection and otitis media. Table 3.1 details 
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the ICD-9-CM and ICD-10-CM codes for each infectious diseases included in our 
analyses.  
Antibiotic Prescribing Patterns: 
The trends of antibiotic prescribing over time was derived from the ‘anti-infective’ 
medication category in the medication files. The medication file was abstracted from the 
electronic medical record and contains the medication name, category name, dosage 
form, and medication dose. The medication file includes all of the antibiotic prescriptions 
that every patient at VCU Health received over the study period in the two clinics that 
we studied, so a patient could have multiple antibiotic prescriptions over the study 
period. Our data has eleven antibiotic categories including macrolides (azithromycin, 
erythromycin), quinolones (ciprofloxacin, levofloxacin), sulfonamides (sulfamethoxazole-
trimethoprim), urinary anti-infectives (nitrofurantoin), penicillins/beta-lactamase inhibitors 
( amoxicillin-clavulanate), miscellaneous antibiotics (metronidazole, rifaximin), 
tetracyclines (tetracycline, doxycycline), first generation cephalosporins (cephalexin), 
second generation cephalosporins (cefuroxime), third generation cephalosporins 
(cefdinir, cefpodoxime), and  aminopenicillins (amoxicillin). The antibiotic prescribing 
trend was tested across all indications in each clinic and individually among the three 
most common infectious diseases (urinary tract infection (UTI), upper respiratory tract 
infection (URI) and skin infection) in the older adult population.       
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Antibiotic Appropriateness:  
To assess oral antibiotic appropriateness, we used a validated method that was 
conducted by Fleming-Dutra et al.15 Fleming-Dutra et al, has developed this tool with 
the help of a team of experts to review national guidelines for antibiotic use for the 
common infectious diseases among outpatient clinics. The criteria categorized antibiotic 
appropriateness into three different tiers based on the clinical diagnosis as follows:  
1. Tier 1: Antibiotics almost always indicated: including UTI, C.diff. Infection and 
pneumonia.  
2. Tier 2: Antibiotics may be indicated: such as acute sinusitis, suppurative otitis 
media, and some types of skin infections.  
3. Tier 3: Antibiotics not indicated: including acute and chronic bronchitis, 
influenza, some type of skin infection, and URI.  
Table 3.2 lists the ICD-9-CM and ICD-10-CM codes for each tier in this analysis.         
Statistical Analysis:  
The demographic characteristics were summarized using descriptive statistics 
(frequency/percentage). Chi-square tests were used to test the relationship between the 
outcomes variables and the categorical demographic variables. To adjust for the clinic 
visit variabilities, we calculated the antibiotic rate normalizing each year by the total 
number of visits for each clinic separately. Trend analysis was performed using the 
Cochran–Armitage test. Logistic regression modeling was performed after checking the 
assumptions, and odds ratio and ninety-five percent confidence intervals were reported 
for all estimates. Variables were included in the model if α equal to 0.1 and all variables 
were considered statistically significant at an α level of 0.05. All the statistical analyses 
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were conducted using the Statistical Analysis Software Version 9.4 (SAS v.9.4), (SAS 
Institute Inc, Cary, NC).       
Ethical Considerations:  
The VCU IRB reviewed and approved this study as exempt (VCU IRB #: 
HM20013584). 
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Table 3.1. The ICD-9-CM and ICD-10-CM codes for each infectious diseases included 
in the study. 
Type of infection ICD-9-CM or ICD-10-CM 
Urinary tract infection  '599' 'N39.0' 
Upper respiratory tract 
infection  
'478.9' '465.9' 'J06.9' '490' '491.21' '466' 'J20.9' 'J40' '491.9' 
'461.9' 'J01.90' '473.9' 'J32.9' 'J01.00' '477.9' 'J30.9' 
Pneumonia  '486' 'Z87.01' 'J18.9' 'J18.8' '516.3' 'B96.1' 
Skin infection '682.6' '682.9' '682.6' '528.3' 'L03.90' 'L03.116' 'L03.115' 
'H60.12' 
Otitis media  '380.1' '381.1' 'H66.93' 'H66.92' 'H66.91' 'H66.90' '382.9' 
'381.4' 
Clostridioides difficile 
infection  
'A04.7' '8.45' 
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Table 3.2. Antibiotics appropriateness criteria according to Fleming-Dutra et al.15 
Diagnosis  Corresponding ICD-9-CM or ICD-10-CM  
Tier 1: Antibiotics almost always indicated: 
Urinary tract infection (UTI) '599' 'N39.0' 
Bacterial pneumonia  '486' 'Z87.01' 'J18.9' 'J18.8' '516.3' 'B96.1'  
Clostridioides difficile infection  'A04.7' '8.45' 
Tier 2: Antibiotics may be indicated: 
Acute sinusitis  '461.9' 'J01.90' '473.9' 'J32.9' 'J01.00'  
Skin, cutaneous and mucosal 
infections 
'382.9' 'H66.90' 'L03.115' 'L03.116' 'L03.90' 
'528.3' '682.6' '682.9' '682.6' 
Suppurative otitis media 'H66.91' '380.1' '381.1' 'H66.93' 'H66.92' 
Tier 3: Antibiotics not indicated:  
Acute and chronic bronchitis, 
bronchiolitis, allergic rhinitis   
'490' '491.21' '466' 'J20.9' 'J40' '491.9' '477.9' 
'J30.9' 
Non-suppurative otitis media '381.4' 
Viral upper respiratory infection (URI) '478.9' '465.9' 'J06.9' 
 
 
 
  
 
 56 
Results:  
Among the 3,515 patients who visited either Geriatrics or Internal Medicine 
ambulatory clinic from 2012-2017, 1,534 antibiotics were prescribed. Most of the 
prescriptions (69%) were prescribed in the Internal Medicine ambulatory clinic 
compared to. 31% of prescriptions initiated from the Geriatrics clinic. A majority of 
Geriatrics clinic antibiotic recipients were 80 years and older (45%), female (77%), and 
white or black (51% and 45%) respectively. In contrast, Internal Medicine ambulatory 
clinic antibiotic recipients were more evenly distributed among the older adult age 
categories. Demographic characteristics are presented in Table 3.3. 
Antibiotic Appropriateness:  
In our study, 43% of antibiotic prescriptions from the Geriatrics clinic were 
considered potentially appropriate, while 50% were considered potentially appropriate in 
the Internal Medicine ambulatory clinic. Potentially inappropriate antibiotic prescriptions 
were similar between the two clinics (30% in Geriatrics clinic and 28% in Internal 
Medicine ambulatory clinic) with p-value 0.08.  Appropriateness of antibiotic prescribing 
is presented in Table 3.4. 
Infectious Diseases Trends: 
Most of the antibiotics in our study were prescribed for six indications: UTI, URI, 
pneumonia, skin infection, C. diff infection and otitis media. Among Internal Medicine 
ambulatory clinic patients, the rate of UTI decreased from 32 diagnoses per 10,000 
visits in 2012 to 23 diagnoses per 10,000 in 2017 compared to Geriatrics clinic patients 
where the UTI rate dropped only slightly from 60 cases per 10,000 visits in 2012 to 56 
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diagnoses per 10,000 visits. Skin infections were the most common infectious diseases 
in 2017 in the Geriatrics clinic. The rate of skin infection in the Internal Medicine 
ambulatory clinic dropped by half from 2012 to 2017 (10 vs. 5 diagnoses per 10,000 
visits) respectively. On the other hand, the rate of skin infection increased in Geriatrics 
clinic from 44 diagnosis per 10,000 visits to 76 diagnosis per 10,000 visits. Figure 3.1 
presents the trend of infectious disease diagnoses from 2012 to 2017 in both clinics.  
Antibiotic Prescribing Trends in Geriatrics Clinic Compared to Internal Medicine a 
Ambulatory Clinic: 
Quinolones, macrolides, and first generation cephalosporins were the most 
common antibiotics prescribed in both clinics over the study period. The directionality of 
the antibiotic rate between the two clinics remained the same from 2012 to 2017 in most 
of the antibiotic categories. For instance, quinolone prescribing in the Geriatrics clinic 
dropped from 179 prescriptions per 10,000 visits in 2012 to 106 prescriptions per 
10,000 visits in 2017. The same pattern was seen in the Internal Medicine ambulatory 
clinic where the quinolone prescribing dropped from 63 prescriptions per 10,000 visits in 
2012 to 30 prescriptions per 10,000 visits in 2017. Likewise, first generation 
cephalosporin prescribing in the Geriatrics clinic increased from 49 prescriptions per 
10,000 visits in 2012 to 126 prescriptions per 10,000 visits in 2017. In the Internal 
Medicine ambulatory clinic, first generation cephalosporin prescribing increased only 
slightly from 15 to 20 prescriptions per 10,000 visits over the 5 year study period. 
Moreover, third generation cephalosporin prescribing increased from 0 to 45 
prescriptions per 10,000 visits among Geriatrics clinic patients, and the same rate was 
observed among Internal Medicine ambulatory clinic patients (3 to 11 prescriptions per 
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10,000 visits over the study period). The rates of prescribing for the eleven antibiotic 
categories are shown in Figure 3.2.        
 
Predictors of Receiving Potentially Inappropriate Antibiotics among Geriatrics 
Clinic Compared to Internal Medicine Ambulatory Clinic: 
Table 3.5 shows the results of multiple logistic regression modeling predicting 
potentially inappropriate antibiotic prescriptions. This analysis showed that Internal 
Medicine clinic providers are significantly (p-value <0.05) less likely to prescribe 
potentially inappropriate antibiotics compared to the Geriatricians in the geriatric clinics 
(OR=0.70 95% CI [0.54-0.90]. Age, gender, race, marital status, hospitalization within 
30 days after an antibiotic prescription, emergency department visit within 30 days after 
an antibiotic prescription were not significant predictors of receiving potentially 
inappropriate antibiotics or potentially appropriate antibiotics. 
 
Antibiotic Treatment for UTI, URI, and skin infections: 
Among UTI patients in both clinics, quinolones and first generation 
cephalosporins were the most common antibiotics prescribed over the study period 
(Figure 3.3). In both clinics, the use of quinolones to treat UTI dropped over time from 
81 to 18 prescriptions per 100 UTI patients in the Geriatric clinic, and from 66 to 36 
prescriptions per 100 UTI patients in the Internal Medicine ambulatory clinic from 2012 
to 2017. The rate of first generation cephalosporin prescribing remained the same over 
time in the Geriatrics clinic, but increased from 15 to 33 prescriptions per 100 UTI 
patients in the Internal Medicine ambulatory clinic.  
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Macrolides, penicillins and quinolones were the most common antibiotic 
categories prescribed to treat URI in both clinics in our study. The rate of macrolide 
prescriptions increased in the Geriatrics clinic while the rate of quinolones and 
penicillins slightly decreased or remained the same (Figure 3.4). 
Finally, tetracyclines, first generation cephalosporins and penicillins were the 
most common antibiotic categories prescribed to treat skin infection for patients in both 
clinics. The rate of tetracycline prescribing dropped from 62 to 26 prescriptions per 100 
skin infection diagnoses from 2012 to 2017 in the Geriatrics clinic. The same trend was 
observed in the Internal Medicine ambulatory clinic where the rate of tetracycline 
prescribing dropped from 58 to 50 prescriptions per 100 skin infections diagnosed. In 
addition, the rate of first generation cephalosporin prescribing increased in the 
Geriatrics clinic and the Internal Medicine ambulatory clinic from (50 to 66 and from 21 
to 37 prescriptions per 100 skin infection diagnosis over the study period respectively) 
(Figure 3.5). 
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Table 3.3. Demographic characteristics among those who were prescribed antibiotics in 
both ambulatory care clinics from 2012 to 2017 
Factor (n=1534) Geriatrics Clinic 
(Freq/%) 
Internal Medicine 
Clinic  
(Freq/%) 
P-Value  
Age (years) 
65-69 
70-74 
75-79 
80 and over 
 
94 (20.13) 
96 (20.56) 
67 (14.35) 
210 (44.94) 
 
384 (35.99) 
245 (22.96) 
229 (21.46) 
209 (19.59) 
<0.0001 
Gender  
Male  
Female  
 
106 (22.70) 
361 (77.30) 
 
255 (23.90) 
812 (76.10) 
0.6100 
Race 
White 
African American  
Other  
 
242 (51.82) 
212 (45.40) 
13 (2.78) 
 
556 (52.11) 
476 (44.61) 
35 (3.28) 
0.8582 
Marital Status  
Married  
Single  
Other  
 
113 (24.20) 
59   (12.63) 
295 (63.17) 
 
364 (34.11) 
527 (49.39) 
176 (16.49) 
<0.0001 
Hospitalization Within 30 
days after an Antibiotic 
prescription  
Yes 
No 
 
 
29 (6.21) 
438 (93.79) 
 
 
63 (5.90) 
1004 (94.10) 
0.8158 
ER visit Within 30 days 
after an Antibiotic 
prescription  
Yes 
No 
 
 
45 (9.64) 
422 (90.64) 
 
 
65 (6.09) 
1002 (93.91) 
0.0176 
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Table 3.4. Antibiotic appropriateness between Geriatrics clinic and Internal Medicine 
ambulatory clinic. 
Antibiotic appropriateness 
(n=1534) 
Geriatric Clinic 
(Freq/%) 
Internal Medicine 
Clinic 
(Freq/%)  
P-Value  
Antibiotics Almost always 
indicated  
203 (43.47) 527 (49.39) 0.0830 
 Antibiotics maybe 
indicated  
125 (26.77) 243 (22.77) 
 Antibiotics not indicated  139 (29.76) 297 (27.84) 
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Table 3.5. Multiple logistic regression modeling assessing predictors of antibiotic 
appropriateness among older adults visiting Geriatrics clinic and Internal Medicine 
ambulatory clinic from 2012-2017. 
Factor (n=1534)  Adjusted Odds Ratio 
[95% CI]) 
 Unadjusted Odds Ratio 
[95% CI]) 
Age (years) 
65-69 
70-74 
75-79 
80 and above  
 
1 [Reference] 
0.83 [0.55-1.26] 
0.61 [0.31-1.19] 
0.37 [0.12-1.11] 
 
1 [Reference] 
0.81 [0.60-1.09] 
0.58 [0.42-0.80] ¶ 
0.37 [0.27-0.50] ¶ 
Gender  
Female 
Male  
 
1 [Reference] 
1.28 [0.97-1.69] 
 
1 [Reference] 
1.28 [0.99-1.66] 
Race  
White 
African American  
Other  
 
1 [Reference] 
1.21 [0.95-1.54] 
0.68 [0.33-1.37] 
 
1 [Reference] 
1.20 [0.95-1.50] 
0.77 [0.39-1.54] 
Marital Status  
Married  
Single  
Other  
 
1 [Reference] 
1.28 [0.90-1.82] 
1.00 [0.75-1.33] 
 
1 [Reference] 
1.32 [0.95-1.84] 
0.81 [0.63-1.04] 
Hospitalization Within 30 
days after an Antibiotic 
Prescription  
No 
Yes 
 
 
1 [Reference] 
0.51 [0.26-1.02] 
 
 
1 [Reference] 
0.50 [0.29-0.87] ¶ 
ER visit Within 30 days of 
after Antibiotic prescription  
No 
Yes 
 
 
1 [Reference] 
1.03 [0.57-1.85] 
 
 
1 [Reference] 
0.72 [0.45-1.14] 
Clinic  
Geriatrics 
Internal Medicine  
 
1 [Reference] 
0.73 [0.56-0.94] ¶ 
 
1 [Reference] 
0.90 [0.71-1.15] 
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Figure  Figure 3.1. The trend of infectious diseases diagnosed among older adults (65 years and older) in 
Internal Medicine and Geriatrics clinic per 10,000 visits at VCU Health from 2012-2017 
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Discussion:  
This study tested the trends of infectious diseases and antibiotic prescribing 
among the older adult population visiting VCU Health over the past five years (2012-
2017) in two ambulatory care clinics (Internal Medicine and Geriatrics clinic). To our 
knowledge, this is the first study to evaluate and compare the antibiotic prescribing 
practices between internal medicine physicians and geriatricians who specialize in the 
care of older adult patients in an academic medical center.   
Overall, the estimate of the rate of potentially inappropriate antibiotic 
prescriptions was 30% in the Geriatrics clinic and 28% in the Internal Medicine clinic. 
Our estimate is higher than previously reported (18% among older adults from National 
Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical 
Care Survey (NHAMCS) data).15 Another study conducted among the Medicare 
population by Olesen, et al.16 reported that the estimate of antibiotic potentially 
inappropriate prescriptions was 40%, which is slightly higher than we observed. 
Although we have used the same methodological approach to define antibiotic 
appropriateness as in the previous studies, the differences we have noted could be 
related to the nature of our data regarding linking and coding the diseases with each 
antibiotic. Also, the differences could be related to regional or institutional practice 
differences. Moreover, in our study uses two years more recent data than Olesen’s 
study, which could explain also the differences in prescribing over time.    
Moreover, we found that UTI, URI, and skin infections are the most common 
infectious diseases among the older adult outpatient population and this is consistent 
with previous reports. 15,11,17 ,18 Among all infectious diseases the trend over time 
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remained the same or only slightly increased/decreased and was not statistically 
significant except for skin infections. Hersh et al., reported that skin and soft infections 
nearly doubled among adults 45 years or older from 1997 to 2005.19 The patterns of 
infectious diseases were the same among both clinics over the study period. This could 
be due to consistency of following diagnostic guidelines within the institution between 
the two clinics. We were unable to test the trend of C.diff infection due to the low 
number of cases documented in our data (C.diff infections= 5 cases overall).  
The most common antibiotic classes prescribed in both clinics were quinolones, 
macrolides, and 1st generation cephalosporins, which is consistent with Olsen et al. and 
other studies.16, 5, 20, 21  We observed that the use of macrolides dropped in 2013 and 
following years in both clinics (Figure 3.2). This behavior could have resulted from a 
safety concern due to the announcement issued in 2013 by the US Food and Drug 
Administration (FDA) warning that azithromycin could cause serious cardiovascular side 
effects and death.22 In addition, the US FDA warned prescribers to restrict the use of 
quinolones as first line therapy to treat certain infections such as acute bacterial 
sinusitis and uncomplicated UTI due to potentially permanent side effects affecting 
muscles, joints, nerves, and central nervous system.23 Likely due to this safety concern, 
we observed a significant reduction in quinolone prescriptions since 2016 (Figures 3.2 & 
Figure 3.4). These findings support that despite efforts to reduce antibiotic prescribing 
(nationally and within VCU Health) safety concerns with specific antibiotics are more 
likely to reduce use than overall concerns about antibiotic resistance.  
We found that geriatricians prescribed more potentially inappropriate antibiotics 
than internal medicine providers. Many factors may contribute to this observation.  One 
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factor may be differences in family/caregiver/patient pressure on geriatricians to 
prescribe an antibiotic compared to internal medicine providers.24 Another possible 
factor is that some of the patients in the geriatrics clinic may live in an assisted living 
facility where the facility care adds pressure to prescribe antibiotics.9 Patients’ 
characteristics, severity of the illness and frailty could be higher in the geriatrics clinic 
which could affect the prescriber’s decision to be more willing to prescribe antibiotics 
assuming that the older adult has a weaker immune system.25,26    
This study has several limitations. First, we used medical record data at VCU 
Health, an academic medical center, which limits the generalizability of our results. 
Second, we have used a validated methodology to evaluate antibiotic appropriateness, 
but that method assumes that the diagnoses are accurate. This is not always the case 
in real world patient care, especially among the older adult population.  For example, 
confusion often arises in distinguishing UTI and asymptomatic bacteriuria.27 Third, only 
a few cases of C.diff infection were documented in the VCU Health outpatient medical 
records, limiting our ability to test for the trend and the predictors of this disease in the 
logistic regression models. Finally, we have tested for ER visit and hospitalization within 
30 days after antibiotic prescribing, and this assumes that the ER visit and 
hospitalization are due to antibiotic use and not any other cause.    
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Conclusion:  
In conclusion, antibiotic inappropriateness is an important issue among older 
adult patients in both Geriatrics and Internal Medicine clinic. Despite the efforts to 
reduce antibiotic prescribing (nationally and within VCU Health) safety concerns with 
specific antibiotics are more likely to reduce use than overall concerns about antibiotic 
resistance. Future studies are needed to evaluate the antibiotic appropriateness in a 
larger level to include more diverse patient population.       
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CHAPTER FOUR 
 
Study 3: Antibiotic Use Among Older Adults Visiting The Emergency Department 
at VCU Health from 2012-2017 
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Background:  
Antibiotic resistance is a serious problem in the United States and worldwide that 
is associated with significant impact on mortality and morbidity among all age groups.1, 2, 
3 According to the World Health Organization (WHO), inappropriate antibiotic use or 
overuse and lack of infection control were associated with increased antibiotic 
resistance.4 A recent nationally representative study reported that antibiotics were one 
of the top ten drug classes highly associated with emergency department (ED) visits for 
adverse events in the United States.5 Several studies have reported that inappropriate 
antibiotic utilization is prevalent among acute respiratory tract infected (ARTI) patients 
visiting the ED.6,7 Sixty-one percent of ARTI patients received antimicrobial therapy and 
older adults had the highest overall rate of antibiotic use compared to other age groups 
(676 per 1,000 visits).  
The ED is an important component of the health care system that provides care 
for vulnerable populations including older adults. In 2015, there were an estimated 21 
million visits by older adult patients to the ED in the US, accounting for 15.6% of all ED 
visits.8 Among all ED patient visits, infectious diseases were one of the top twenty 
primary diagnoses. In 2012, there were an estimated 3,123,909 ED visits due to 
infectious diseases among older adults.9 Moreover, the geriatric population is the most 
common age group visiting the ED due to adverse drug reactions.10  
Many Americans rely on the ED for health care due to difficulties accessing primary 
care offices and several other barriers reported previously.11 Although there are national 
and global initiatives to combat antibiotic resistance by improving antibiotic prescribing 
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practices in all settings, there is little known about antibiotic use among geriatric 
populations in the ED. Therefore, the specific aims for this study are to:  
1. Assess the trend of antibiotic use and infectious diseases among older adult 
patients aged 65 years or older visiting the ED at VCU Health from 2012-2017.   
2. Assess the trend of antibiotic use and infectious diseases among middle aged 
patients aged 54 to 64 years visiting the ED at VCU Health from 2012-2017. 
3. Compare the antibiotic appropriateness between older adult patients and middle-
aged patients visiting the ED at VCU Health from 2012-2017. 
4. Assess the relationship between antibiotic appropriateness and socio-
demographic characteristics, age group and antibiotic negative outcomes 
including ED visits within 30 days after the initiation of antibiotics and 
hospitalization within 30 days after the initiation of antibiotics. 
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Methods:  
Data Source:  
The ED electronic medical records at VCU Health from 2012-2017 were used in 
this study. The complete data was available through Cerner (Kansas City, Missouri, 
U.S.) by the beginning of 2012, so we abstracted the data starting from that date. The 
year 2017 was the most recent complete data available at the time of data 
retrieval.  VCU Health is an urban academic medical center in central Virginia. The data 
was retrieved from the electronic medical records and billing records by the 
Bioinformatics core of the VCU Center for Clinical and Translational Research (CCTR). 
Study Design and sample selection: 
A cross-sectional retrospective cohort study design was used to conduct this 
study using the electronic medical records at VCU Health from 2012-2017.  
Inclusion and Exclusion Criteria:  
Only older adult patients (65 years or older) and middle-aged patients (54-64 
years of age) who received antibiotic prescriptions during their ED visit at VCU Health 
from 2012-2017 were included in this study. Oral and intravenous antibiotic 
prescriptions were included in the study. All patients who received an antibiotic 
prescription within 2 days of hospital discharge were excluded from the study to avoid 
including hospital-related infections. Patients who received an antibiotic prescription that 
was not prescribed on the day of the ED visit were excluded from the study. Any 
patients diagnosed with a viral infection were excluded as well. Finally, any patient with 
missing information in the medication file or diagnosis file was excluded from the study.  
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Study Measures:  
Demographic Characteristics:  
Age, race, gender and marital status were collected from VCU Health’s ED 
electronic medical records. Age was treated as categorical variable and categorized into 
2 groups: older adults (65 years or older) and middle-aged adults (54-64 years of age). 
Age was censored as patients 80 years or older were grouped together and their actual 
age was not included in the dataset to protect patient confidentiality. The race variable 
was categorized as white, African American, and other. The ‘other’ category in the race 
variable includes American Indian/Alaskan, Asian, Native Hawaiian, and other. The 
gender variable was categorized as male or female. Marital status was categorized as 
married, single, and other. The ‘other’ category included divorced, separated, and 
widowed.  
Outcomes Measures:  
Antibiotic Use Patterns: 
Antibiotic use determination included only the medications classified as ‘anti-
infective’ in the prescription files. The medication file was abstracted from the ED 
electronic medical records (Cerner, Kansas City, Missouri, U.S.) and included the 
medication name, category name, and strength. The medication file contains all of the 
antibiotic prescriptions that each patient received over the study period, so a patient 
could have multiple antibiotic prescriptions over the study period related to multiple ED 
visits. Our dataset comprises eleven antibiotic categories including macrolides 
(azithromycin, erythromycin), quinolones (ciprofloxacin, levofloxacin), sulfonamides 
(sulfamethoxazole-trimethoprim), urinary anti-infectives (nitrofurantoin), penicillins/beta-
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lactamase inhibitors ( amoxicillin-clavulanate), miscellaneous antibiotics (metronidazole, 
rifaximin), tetracyclines (tetracycline, doxycycline), first generation cephalosporins 
(cephalexin), second generation cephalosporins (cefuroxime), third generation 
cephalosporins (cefdinir, cefpodoxime), Lincomycin derivatives (clindamycin) 
and  aminopenicillins (amoxicillin). The trend of antibiotic prescribing over time was 
tested across all indications in each age group and also separately for the three most 
common infectious diseases in the older adult population (urinary tract infection (UTI), 
upper respiratory tract infection (URI) and skin and soft tissue infection).       
Infectious Disease Diagnoses:  
The infectious disease diagnoses in the VCU Health data were identified using 
the International Classification of Diseases ICD-9-CM codes assigned to each patient 
during the ED visit. VCU Health converted to ICD-10-CM coding by the end of 2015, so 
in our analysis, we have used both ICD-9-CM and ICD-10-CM codes. We included the 
most common infectious diseases among older and middle-aged patients visiting the 
VCU Health ED, which include UTI, URI, skin and soft tissue infections, pneumonia, 
Clostridioides difficile (C. diff) infection and otitis media. Table 4.1 details the ICD-9-CM 
and ICD-10-CM codes used to identify each infectious disease.  
Antibiotic Appropriateness:  
To estimate oral antibiotic appropriateness we used a validated method developed 
by Fleming-Dutra et al.12 This study used a comprehensive methodology with a team of 
experts systematically reviewing the national guidelines for antibiotic use for common 
infectious diseases among the older adult population. The criteria for antibiotic 
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appropriateness categorized antibiotic use into three tiers based on the clinical 
diagnosis as follows:  
1. Tier 1: Antibiotics almost always indicated: includes UTI, C.diff. infection and 
pneumonia.  
2. Tier 2: Antibiotics may be indicated: includes acute sinusitis, suppurative otitis 
media, and some type of skin and soft tissue infections.  
3. Tier 3: Antibiotics not indicated: Acute and chronic bronchitis, influenza, some 
types of skin and soft tissue infection, and URI.  
All the ICD-9-CM and ICD-10-CM codes included in each category are listed in Table 
4.2.          
Statistical Analyses:  
Demographic characteristics were summarized by descriptive analyses 
(frequency/percentage). Chi-square tests were used to assess the relationship between 
the outcomes variables and the categorical demographic variables. To adjust for the ED 
visit variability between age groups, we calculated the antibiotic rate normalizing each 
year by the total ED visits for each age group separately. Trend analysis was performed 
using the Cochran–Armitage test. A logistic regression model was developed after 
checking that the assumptions of the model were met, and odds ratios and ninety-five 
percent confidence intervals were reported for all estimates. All variables with α equal to 
0.1 or less were included in the model and all variables were considered statistically 
significant at α level of 0.05 or less. Statistical analyses were conducted using the 
Statistical Analysis Software Version 9.4 (SAS v.9.4 (SAS Institute Inc, Cary, NC)).       
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Ethical Considerations:  
The Virginia Commonwealth University Institutional Review Board (VCU IRB) 
reviewed and approved this study as exempt (VCU IRB NO: HM20013606).  
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Table 4.1. ICD-9-CM and ICD-10-CM codes for each infectious disease included in the 
study. 
Type of infection ICD-9-CM or ICD-10-CM 
Urinary tract infection  '599' 'N39.0' 
Upper respiratory tract 
infection  
'478.9' '465.9' 'J06.9' '490' '491.21' '466' 'J20.9' 'J40' '491.9' 
'461.9' 'J01.90' '473.9' 'J32.9' 'J01.00' '477.9' 'J30.9' 
Pneumonia  '486' 'Z87.01' 'J18.9' 'J18.8' '516.3' 'B96.1' 
Skin and soft tissue 
infection  
'682.6' '682.9' '682.6' '528.3' 'L03.90' 'L03.116' 'L03.115' 
'H60.12' 
Otitis media  '380.1' '381.1' 'H66.93' 'H66.92' 'H66.91' 'H66.90' '382.9' 
'381.4' 
Clostridioides difficile 
infection  
'A04.7' '8.45' 
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Table 4.2. Antibiotic appropriateness criteria according to Fleming-Dutra, et al.12    
Diagnosis  Corresponding ICD-9-CM or ICD-10-CM  
Tier 1: Antibiotics almost always indicated: 
Urinary tract Infection '599' 'N39.0' 
Bacterial pneumonia  '486' 'Z87.01' 'J18.9' 'J18.8' '516.3' 'B96.1'  
Clostridioides difficile infection  'A04.7' '8.45' 
Tier 2: Antibiotics may be indicated: 
Acute sinusitis  '461.9' 'J01.90' '473.9' 'J32.9' 'J01.00'  
Skin, cutaneous and mucosal 
infections 
'382.9' 'H66.90' 'L03.115' 'L03.116' 'L03.90' 
'528.3' '682.6' '682.9' '682.6' 
Suppurative otitis media 'H66.91' '380.1' '381.1' 'H66.93' 'H66.92' 
Tier 3: Antibiotics not indicated:  
Acute and chronic bronchitis, 
bronchiolitis, allergic rhinitis   
'490' '491.21' '466' 'J20.9' 'J40' '491.9' '477.9' 
'J30.9' 
non-suppurative otitis media '381.4' 
viral upper respiratory infection (URI) '478.9' '465.9' 'J06.9' 
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Results:  
Demographic Characteristics:  
The sample size of this study is 6,343 middle-aged or older adult patients who 
received an antibiotic dispensed and prescribed in the ED at VCU Health from 2012 to 
2017. The proportion of antibiotic prescriptions was evenly distributed across both 
genders and age groups. A higher proportion of whites and African Americans received 
antibiotic prescriptions compared to other races. Moreover, 14% of middle-aged 
patients who were prescribed antibiotics in the ED visited the ED again within 30 days 
following that prescription compared to 11% among older adult patients. Table 4.3 
details the demographic characteristics of antibiotic users in the ED at VCU Health from 
2012-2017 in both age groups.    
Antibiotic Appropriateness:  
Among all of the antibiotic prescriptions that older adults received in the ED, 90% 
were considered potentially appropriate, compared to 81% among middle-aged 
patients. Eighteen percent of the antibiotic prescriptions received by the middle age 
group were considered potentially inappropriate, compared to 9% among the older adult 
patient. Antibiotic appropriateness practices were statistically different between different 
antibiotic appropriateness tiers (p < 0.0001) (Table 4.4).         
Infectious disease trends among older adult patients compared to middle- aged 
patients: 
In our study, most of the antibiotic indications were limited to six infectious 
diseases including UTI, URI, pneumonia, skin and soft tissue infection, C. diff infection, 
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and otitis media. In both age groups, the trend of infectious diseases seemed to be 
stable from 2012-2017 except for three diseases: UTI, URI, and pneumonia. The three 
most common infectious diseases among the middle-aged group were UTI, URI, and 
pneumonia. Among middle-aged patients, URI dropped from 180 diagnoses per 10,000 
ED visits in 2012 to 76 diagnoses in 2017. The same trend was observed in the UTI 
diagnoses which declined from 136 diagnoses per 10,000 ED visits in 2012 to 122 
diagnoses in 2017. The opposite trend was seen with pneumonia, where the cases 
increased from 83 cases per 10,000 ED visits in 2012 to 102 cases in 2017. Among 
older adults, UTI, pneumonia, URI and skin and soft tissue infections were the most 
common diagnoses seen in the ED visits over the study period. UTI rates were stable 
over the study period, while URI rates dropped from 98 to 54 cases per 10,000 ED visits 
among older adults from 2012 to 2017. C.diff infection rates were stable over the study 
period in both age groups. Figure 4.1 shows the trends over time from 2012-2017 in 
both age groups at the ED at VCU Health.  
Antibiotic trends among older adult patients compared to middle-aged patients:  
Interestingly, we observed similar trends in terms of antibiotic prescriptions by 
category between middle-aged and older adult patients visiting the ED at VCU Health 
from 2012-2017 (Figure 4.2). Quinolones, penicillins, first generation and third 
generation cephalosporins were the most common antibiotic classes prescribed in both 
age groups. The rate of quinolone prescriptions dropped slightly over time in middle-
aged and older adults (from 215 to 206 and 400 to 372 per 10,000 ED visits, 
respectively). On the other hand, the rate of penicillins almost doubled in middle-aged 
and older adults (from 179 to 334 and from 288 to 541 per 10,000 ED visits, 
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respectively). Third generation cephalosporin prescriptions were stable most of the 
study period and increased from 2016 to 2017 in both age groups. The same 
observations were seen with the remaining antibiotic categories.   
Predictors of Receiving Potentially Inappropriate Antibiotics Among Older Adult 
Patients Compared to Middle-Aged Patients:  
Table 4.5 presents the results of multiple logistic regression model analysis 
predicting potentially appropriate versus potentially inappropriate antibiotic prescriptions 
with demographic characteristics and outcomes of interest as predictors. Multiple 
logistic regression modelling found that middle-aged patients were 70% significantly 
more likely to be prescribed potentially inappropriate antibiotics compared to older adult 
patients adjusting for other predictors (95% CI [1.38-2.06]. African Americans, single 
adults, and non-insured patients were significantly more likely to be prescribed 
potentially inappropriate antibiotics in the ED at VCU Health adjusting for other 
covariates. Gender and hospitalization or ED visits within 30 days after an antibiotic 
prescription were not associated with antibiotic potentially inappropriateness practices in 
the ED at VCU Health.         
Antibiotic Prescribing for UTI, URI, and Skin and soft tissue Infections:  
Among patients diagnosed with UTI in both age groups, third generation 
cephalosporins, quinolinones, penicillins, and first generation cephalosporins were the 
most common antibiotic categories prescribed over the study period (Figure 4.3). The 
rate of quinolone prescriptions to treat UTIs in the ED dropped in older and middle-aged 
patients from 22 prescriptions per 100 UTI diagnosis to 14, and from 19 to 7 
respectively from 2012-2017. In contrast, the rate of penicillin prescribing almost 
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doubled over the study period from 6 prescriptions per 100 UTI diagnosis in 2012 to 15 
in 2017 among older adult patients. A similar trend was observed in the middle-aged 
group, with penicillin prescribing increasing from 7 to 16 prescriptions per 100 UTI 
diagnoses from 2012-2017.  
Figure 4.4 shows the antibiotic prescribing rate over time for the treatment of 
patients with URI in both age groups. Macrolides, quinolones, tetracyclines and 
penicillins were the most common antibiotic categories prescribed to treat URI in both 
age groups. Among older adults who were treated for URI, the rate of macrolide, 
quinolone, and penicillin prescriptions more than doubled over the study period. In 
contrast, the rate of prescribing of all antibiotic categories dropped from 2012-2017 
among middle-aged patients except for penicillins.  
In our study, the treatment options for skin and soft tissue infections were limited 
to clindamycin, penicillins, 1st generation cephalosporins, and tetracyclines. The rate of 
penicillin prescribing increased significantly among older adults and middle-aged 
patients, from 32 prescriptions to 46 per 100 skin and soft tissue infection diagnoses, 
and from 18 to 45 prescriptions per 100 skin and soft tissue infection diagnoses 
respectively. Figure 4.5 presents the treatment of patients diagnosed with skin infected 
by antibiotic category from 2012-2017.           
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Table 4.3. Demographic characteristics of those who received antibiotics in the 
emergency department at VCU Health by age group from 2012 to 2017. 
Factors (n=6343) Aged 54-64 years 
(Freq/%) 
Aged 65 years and 
older (Freq/%)  
P-Value  
Gender  
Male  
Female  
 
1725 (54.83) 
1605 (50.20)  
 
1421 (45.17) 
1592 (49.80) 
0.0002 
Race 
White 
African American  
Other  
 
1337 (47.34) 
1821 (56.96) 
169 (55.23) 
 
1487 (52.66) 
1376 (43.04) 
137 (44.77) 
<0.0001 
 
Marital Status  
Married  
Single  
Other  
 
969 (46.52) 
1181 (65.68) 
1163 (48.38) 
 
1114 (53.48) 
617 (34.32) 
1241 (51.62) 
<0.0001 
Hospitalization within 30 
days of an antibiotic 
prescription  
Yes 
No 
 
 
 
301 (9.04) 
3029 (90.96) 
 
 
 
288 (9.56) 
2725 (90.44) 
0.4765 
ED visit within 30 days of 
an antibiotic prescription  
Yes 
No 
 
 
472 (14.17) 
2858 (85.83) 
 
 
345 (11.45) 
2668 (88.55) 
0.0012 
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Table 4.4. Antibiotic prescribing appropriateness by age group at the emergency department, 
VCU Health from 2012-2017. 
Antibiotic appropriateness 
(n=6343) 
54-64 years old 
(Freq/%) 
65 and older 
(Freq/%) 
P-Value  
Antibiotics Almost always 
indicated  
2700 (81.08) 2722 (90.34) <.0001 
 Antibiotics maybe indicated  26 (0.78) 17 (0.56) 
 Antibiotics not indicated  604 (18.14) 274 (9.09) 
 
 
 
Table 4.5. Multiple logistic regression model assessing predictors of antibiotic 
appropriateness among older adults and middle-aged patients visiting the emergency 
department at VCU Health from 2012-2017. 
Factors (n=6343) Adjusted Odds Ratio [95% 
CI]) 
Unadjusted Odds Ratio [95% 
CI]) 
Age (years) 
65 and older 
54-64  
 
1 [Reference]  
2.14 [1.82-2.50]¶ 
 
1 [Reference] 
2.30 [1.97-2.68] ¶ 
Gender  
Female  
Male  
 
1 [Reference] 
0.98 [0.84-1.13] 
 
1 [Reference] 
0.95 [0.82-1.10] 
Race  
White 
African American  
Other  
 
1 [Reference] 
1.46 [1.24-1.71] ¶ 
1.25 [0.87-1.81] 
 
1 [Reference] 
1.73 [1.49-2.02] ¶ 
1.23 [0.85-1.76] 
Marital Status  
Married 
Single  
Other  
 
1 [Reference] 
1.58 [1.29-1.93] ¶ 
1.53 [1.26-1.86] ¶ 
 
1 [Reference] 
2.06 [1.70-2.49] ¶ 
1.70 [1.41-2.04] ¶ 
Hospitalization within 30 days 
of an antibiotic prescription  
No 
Yes 
 
 
1 [Reference] 
0.65 [0.47-0.90] 
 
 
1 [Reference] 
0.71 [0.54-0.93] 
ED visit within 30 days of an 
antibiotic prescription  
No 
Yes 
 
 
1 [Reference] 
1.30 [1.02-1.65]¶ 
 
 
1 [Reference] 
1.21 [0.98-1.48] 
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Figure 4.3.  Figure 4.1.  The trend of infectious disease diagnoses per 10,000 visits among older adults (65 
years and older) and middle- aged adults (54-64 years) in the emergency department at VCU 
Health from 2012-2017 
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Figure 4.2.  The trend of antibiotic prescriptions per 10,000 visits among older adults (65 years and 
older) and middle-aged adults (54-64 years) in the emergency department at VCU Health from 2012-
2017 
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Figure 4.5. The trend of antibiotic prescribing for skin infections per 100 skin infection diagnoses 
among older adult patients (65 years and older) and middle-aged adults (54-64 years) in the 
emergency department at VCU Health from 2012-2017 
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Discussion:  
Our study evaluated the trend of infectious disease diagnoses and antibiotic 
prescribing practices among older and middle-aged patients visiting the ED at VCU 
Health from 2012-2017. This study presents the most common infectious diseases 
diagnosed in the ED, and the most common antibiotics prescribed in the same setting. 
In addition, we have evaluated the antibiotic prescribing practices for the most common 
infectious diseases among older adult patients including, UTI, URI, and skin and soft 
tissue infections. To the best of our knowledge, the trend of infectious diseases and 
antibiotic appropriateness presenting at the ED in academic medical centers is still 
unclear among older adult populations. This is the first study to compare antibiotic 
appropriateness between older adults and middle age patients at the ED.   
Inappropriate antibiotic use has been documented as a risk factor for antibiotic 
resistance.13,14,15  The overall estimate of potentially inappropriate antibiotic 
prescriptions in our study was 27%, similar to previous reports of 24% in the ED16 and 
18% based on data from the  National Ambulatory Medical Care Survey (NAMCS) 
which included an ED patients,12 but lower than the 40% reported by Olesen, et al.17 in 
the Medicare population. The Olesen, et al. study was not limited to ED patients, but 
included outpatients as well.17 Nine percent of older adults’ antibiotic prescriptions were 
deemed potentially inappropriate, which was lower than the 18% observed in middle-
aged patients, but this percentage may still be an important contributor to unnecessary 
hospital admissions, preventable adverse drug reactions or unnecessary health care 
costs. 
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Goto, et al.9 found in a recent study conducted using nationally representative 
data that lower respiratory infection, UTI, and pneumonia were among the five most 
common infectious diseases among older adults visiting the ED, similar to what we 
observed among older adult patients. The same pattern was found by Stone et al 
among ED patients.7 except that skin and soft tissue infections were the most common 
indications for antibiotic prescribing in the ED among all age groups.  
Our results suggested that ED providers prescribed broad-spectrum antibiotics 
more than narrow-spectrum antibiotics and that could be due to the nature of the ED 
diagnosis process. For instance, quinolones and penicillins were the most commonly 
prescribed antibiotics in the ED. Although the Food and Drug Administration (FDA) 
released in 2016 a warning regarding the use of quinolones as a first-line therapy due to 
serious adverse events, we observed an increase in quinolone prescribing.18 This 
behavior could be due to the antimicrobial susceptibility patterns in our study suggested 
empiric treatment with quinolones rather than other antibiotic classes. In addition, a 
possible explanation of the increased use of all antibiotic categories since 2016 was due 
to the fact of CMS requiring all hospitals to implement the sepsis core measures.19  
This study has several limitations. First, while we examined six years of data and 
our sample size was large, our study was limited to one large academic medical center 
and we cannot generalize our findings to other academic medical centers in the US.  
Second, although we have used a validated definition of antibiotic appropriateness, the 
definition relies only on the indication of each antibiotic prescription and assumes that 
the diagnosis is accurate. For instance, all of the UTI diagnoses were considered 
accurate, while in real world scenarios they can sometimes be inaccurate due to the 
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confusion between UTI, which should be treated with antibiotics, and asymptomatic 
bacteriuria, which should not be treated with antibiotics. Third, we have evaluated ED 
visits and hospitalization within 30 days following antibiotic prescribing as negative 
outcomes related to antibiotic consumption while in reality there are other potential 
causes for the ED visits and hospitalizations we observed.  Finally, our findings derive 
from secondary analysis of data from electronic health records, and our results could be 
underestimated or overestimated due to possibly inaccurate ICD-9/10 coding in the 
medical records.  
Conclusion:  
In conclusion, Geriatric patients received fewer potentially inappropriate antibiotic 
prescriptions compared to middle-aged patients. This study provides trend analysis 
regarding the most common antibiotics prescribed for both older adults and middle-aged 
patients, and this analysis could help to improve antibiotic prescribing practices in the 
future among all ages and especially older adults who are at high risk of medication 
complexity. This analysis can serve as a baseline to understand the impact of 
interventions to improve antimicrobial use in the ED in the future. It can also be 
benchmarked against prescribing in the ED in other academic medical centers to inform 
development of best practices for antimicrobial stewardship in the ED in safety net 
hospitals. 
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Summary of Findings:  
This dissertation consists of three investigations of issues related to antibiotic use 
and associated complications among older adult patients visiting different health care 
settings from the emergency department (ED) to outpatient clinics. The first study 
examined the trend of antibiotic use among community-dwelling older adults using a 
nationally representative dataset, the Medical Expenditure Panel Survey (MEPS), from 
2011-2015. In this study, we evaluated the trend of common infectious diseases and the 
association between antibiotic use and demographic characteristics, sociodemographic 
characteristics, and the negative outcomes of antibiotic use such as ED visits. The 
second study calculated the trend of antibiotic use and common infectious diseases 
among older adult patients visiting VCU Health in two different outpatient clinics, 
Geriatrics clinic and adult Internal Medicine clinic, from 2012-2017. We evaluated and 
compared the antibiotic prescribing appropriateness practices between the two clinics. 
The third study described the trend of antibiotic prescriptions among older adult patients 
and compared it with middle-aged patients visiting the ED at VCU Health from 2012-
2017. This study evaluated antibiotic use predictors and the prescribing appropriateness 
practices between older adult patients and middle-aged patients. This chapter presents 
the highlights of the main findings, implications of the studies’ results, and possible 
future research.  
Thirty-one percent of community-dwelling U.S. older adults reported using 
antibiotics, accounting for 105,762,134 prescriptions from 2011-2015. In addition, the 
overall rate of antibiotic prescriptions increased slightly over the study period from 484 
prescriptions per 1,000 persons in 2011 to 540 prescriptions per 1,000 persons in 2015. 
 
 106 
This rate is higher than the rate of antibiotic use among a younger adult population in 
2010 where a study reported that the rate was 354 prescriptions per 1,000 persons.1 
Several previous studies have reported mixed results regarding the antibiotic rate 
among younger adults compared to an older adult population. These differences in the 
overall antibiotic rate are possibly due to the nature of the dataset, and the 
methodological approach for assessing antibiotic prescriptions. For those reasons it is 
difficult to directly compare the antibiotic trends between populations using different 
datasets. To the best of our knowledge, this study uses the most recently available data 
to evaluate antibiotic use among older adult patients using nationally representative 
data. Our analysis found that the rate of antibiotic prescribing varied by age group. 
Younger older adults (65-69) received more antibiotic prescriptions compared to the 
oldest-old group (80 years of age or older). Interestingly, antibiotic users were more 
likely to visit the ED compared to non-users. Our analysis estimated that upper 
respiratory tract infections were the most common antibiotic indications from 2011-2015, 
and most of these indications do not require antibacterial therapy. Among antibiotic 
users, macrolides, quinolones, and penicillins were the most common antibiotic 
categories prescribed in the U.S. The rate of macrolide prescribing significantly 
decreased while penicillins prescribing rates increased over the study period. These 
findings support the hypothesis that health care professionals may not be reducing their 
prescribing of antibiotics in response to calls to reduce use to avoid antibiotic 
resistance, but rather they are changing prescribing from one antibiotic category to 
another perhaps in response to drug safety concerns.  
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Among VCU Health patients visiting adult ambulatory care clinics, Internal Medicine 
clinic providers prescribed more antibiotic prescriptions compared to the Geriatrics clinic 
(69% vs. 31%) respectively. In addition, we found that Geriatrics clinic providers 
prescribed more potentially inappropriate antibiotic prescriptions compared to Internal 
Medicine clinic providers. We may expect that the geriatrics patients are more likely to 
have compromised immune response and that the geriatricians are erring on the side of 
caution. In addition, patients visiting the geriatrics clinics are considered complex 
patients, which means they are sicker than the Internal Medicine patients and older as 
well. The rate of common infectious diseases among VCU Health patients was similar to 
the national findings where UTI, URI, and skin infections were observed to be the most 
common antibiotic indications. In addition, we observed similar patterns of antibiotic 
categories prescribed between Internal Medicine clinic and the Geriatrics clinic with 
quinolone and macrolide use decreasing over time and penicillins increasing slightly 
along with first-generation cephalosporins. We found that the patterns of antibiotic 
categories prescribed varied by the indication and were consistent with national 
guidelines.2,3,4  
Among the VCU Health ED patients, we found that older adult patients were 
significantly less likely to receive potentially inappropriate antibiotic prescriptions 
compared to middle-aged patients. In both age groups, UTI, URI, and pneumonia were 
the three most common indications for antibiotic prescriptions. Similar to the previous 
studies’ findings, broad-spectrum antibiotic prescribing was common in the ED patients, 
irrespective of the age of the patients. Penicillins and quinolones were the most 
common antibiotics prescribed for ED patients from 2012-2017 at VCU Health. 
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Moreover, we found differences in the antibiotic categories prescribed based on the 
indications in both age groups. Our findings from the studies at VCU Health are limited 
in their generalizability to other academic medicine centers or other care settings. The 
choice of the antibiotic prescribed depends in part on the formulary system and this is 
likely to vary from one hospital to another.      
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Implications:  
Most of the previous studies of antibiotic use in the U.S. were not focused on the 
older adult population specifically, a population that could be affected negatively by 
antibiotic overuse or misuse due to several factors such as polypharmacy, 
comorbidities, and normal biological and physiological changes with age that could 
affect antibiotic pharmacokinetics/pharmacodynamics. Our nationally representative 
findings could be used to evaluate the impact of national antimicrobial stewardship 
programs and the National Action Plan for Combating Antibiotic-Resistant Bacteria for 
decreasing the antibiotic resistance in 2020 as the programs are implemented by 
establishing a baseline for comparison. These findings could also be used to compare 
antibiotic prescribing and infectious diseases trends to those observed in different 
datasets such as Medicare claims data. The findings from the VCU Health System 
could be used to improve health care provider treatment practices in the care of older 
adults, including practices in the Geriatrics clinic. Comparing our results with the 
hospital antibiogram would be useful for the hospital administration to evaluate the 
antibiotic stewardship program in the hospital. In addition, our findings could help other 
health care providers like nurse practitioners and pharmacists to evaluate their 
knowledge, practices towards antibiotic use among vulnerable population like older 
adults and identify opportunities to improve care for this population and reduce the risk 
of outcomes such as antibiotic resistance.     
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Future Research:  
In our retrospective cohort studies, we have assessed the antibiotic prescribing trends 
on a national level and local level. In addition, we have evaluated antibiotic 
appropriateness based on the ICD-codes, assuming the diagnosis is correct. Future 
studies could test antibiotic prescription appropriateness through a more robust 
definition taking into consideration the antibiotic susceptibility of each patient, accurate 
diagnosis and lab culture, age-appropriate dosing and choice of antibiotic, and risk of 
drug interactions. Moreover, antibiotic inappropriateness could be defined in different 
ways, such as a patient receiving an antibiotic from a friend or family member or an 
individual not following the correct directions for use. Taking all these factors into 
consideration when defining antibiotic appropriateness measures will strengthen the 
definition and the study’s findings.  
In the three studies that we have conducted, we examined antibiotic use among 
non-institutionalized older adults. Previous studies have shown that antibiotic 
prescribing rates among older adult patients in the nursing home is high. The same 
study objectives need to be replicated among nursing home residents using the most 
recent nationally representative data. On the other hand, assisted living residents share 
common characteristics with both community-dwelling older adults and nursing home 
residents such as age, polypharmacy, and comorbidities that could affect the 
medication prescription practices. There is a lack of research evaluating prescribing 
practices in assisted living facilities. Unlike inpatient or nursing home settings, assisted 
living facilities are a social model, not a medical model. For that reason, it is very difficult 
to collect medical information regarding assisted living residents. Also, it is expensive 
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and time and resource exhausting. A study that would compare and evaluate antibiotic 
prescription practices among outpatient community older adults, nursing home 
residents, and assisted living facilities residents would be ideal research questions for 
future researchers. 
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Appendix For Study 2  
 
 
 
 
 
  
  Appendix: 3.1 Infectious Diseases Trend in Internal Medicine Ambulatory Clinic per 10,000 visits 
Type of Infection 2012 2013 2014 2015 2016 2017 P-value  
UTI 32.54149 38.58728 30.64295 31.05939 27.66742 23.72053 0.4745 
URI 31.45677 25.72485 29.00137 17.58785 31.21453 28.39275 0.1286 
Pneumonia  5.96594 4.287475 1.641587 2.619466 2.837684 3.234618 0.305 
Skin Infection 10.30481 11.79056 7.660739 2.993676 4.611237 5.750431 0.0021 
C.Diff 0 0 0 0 0 0.359402 0.0514 
Otitis Media 3.254149 2.143738 2.735978 1.122628 2.482974 1.79701 0.809 
Type of Infection 2012 2013 2014 2015 2016 2017 p-value  
UTI 60.84071 73.52941 71.71483 77.50397 78.18317 55.58363 0.9833 
URI 99.55752 71.07843 78.04261 107.3132 63.29114 60.63669 0.2798 
Pneumonia 5.530973 4.901961 14.76482 21.8601 3.723008 10.10611 0.4479 
Skin Infection 44.24779 39.21569 14.76482 31.7965 33.50707 75.79586 0.3321 
C.Diff 0 0 0 1.987281 0 0 0.705 
Otitis Media  0 0 6.327779 0 0 0 0.5651 
Appendix 3.2 Infectious Diseases Trend in Geriatrics Clinic per 10,000 visits 
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2012 2013 2014 2015 2016 2017 
 
Quinolones 176.9912 137.2549 166.6315 176.868 152.6433 106.1142 
 
Macrolides 99.55752 88.23529 80.15187 99.36407 78.18317 80.84891 
 
Tetracyclines 49.77876 68.62745 37.96667 65.58029 44.6761 75.79586 
 
First generation 
Cephalosporins 
49.77876 58.82353 59.05927 61.60572 81.90618 126.3264 
 
Second generation 
Cephalosporins 
0 7.352941 2.10926 1.987281 7.446016 10.10611 
 
Third generation 
Cephalosporins 
0 2.45098 8.437039 17.88553 40.95309 45.47751 
 
Aminopenicillins 38.71681 34.31373 37.96667 41.73291 29.78407 70.7428 
 
urinary anti-infectives 11.06195 12.2549 10.5463 19.87281 26.06106 35.3714 
 
Miscellaneous Antibiotics 27.65487 24.5098 27.42038 23.84738 22.33805 25.26529 
 
Penicillins  22.12389 31.86275 50.62223 53.6566 44.6761 65.68974 
 
Sulfinamides  27.65487 34.31373 16.87408 17.88553 7.446016 5.053057 
 
 
 
 
  
Appendix 3.3 Antibiotic Prescriptions Trend among Geriatrics Clinic per 10,000 visits 
Appendix 3.4 Antibiotic Prescriptions trend among Internal Medicine Ambulatory Care Clinic per 10,000 visits 
Antibiotic Category  2012 2013 2014 2015 2016 2017 p-value  
Quinolones 63.45591 52.52157 46.51163 37.42095 40.08229 30.54917 0.0035 
Macrolides 55.32053 42.87475 45.41724 30.31097 40.437 32.70558 0.333 
Tetracyclines 21.15197 24.65298 21.88782 14.96838 20.57321 20.12651 0.26 
First generation 
Cephalosporins 
15.18603 13.39836 16.96306 11.60049 21.28263 20.48591 <.0001 
Second generation 
Cephalosporins 
0 1.071869 1.094391 0.748419 1.418842 1.79701 0.0403 
Third generation 
Cephalosporins 
2.711791 2.679672 2.188782 3.742095 5.320658 10.78206 <.0001 
Aminopenicillins 27.66027 17.68584 12.0383 7.48419 9.931896 10.06325 0.0002 
urinary anti-infectives 8.135373 2.679672 9.302326 10.47787 6.030079 5.391029 0.4684 
Miscellaneous Antibiotics 13.55895 9.110885 7.113543 6.361561 8.158343 6.109833 0.2539 
Penicillins  11.38952 10.18275 10.39672 10.85207 14.18842 15.09488 0.0013 
sulfonamides 11.38952 6.431213 8.207934 5.238933 3.547106 5.031627 0.061 
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Appendix 3.4 Antibiotic Treatment Among UTI patients in Geriatrics Clinic Per 100 UTI Diagnoses 
 
 
 
Appendix 3.5 Antibiotic Treatment Among UTI Patients in Internal Medicine Ambulatory Care Clinic 
Per 100 UTI Diagnoses  
 
 
 
 
 
 
 
 
 
 
 Antibiotic Category  2012 2013 2014 2015 2016 2017 P-value  
Quinolones  81.81818 36.66667 61.76471 56.41026 52.38095 18.18182 0.096 
Macrolides 0 6.666667 0 0 4.761905 0 0.5408 
Tetracyclines 0 3.333333 2.941176 2.564103 0 9.090909 0.6706 
First generation 
Cephalosporins 
9.090909 23.33333 23.52941 10.25641 9.52381 9.090909 0.1424 
Second generation 
Cephalosporins 
0 0 0 0 4.761905 9.090909 0.0309 
Third generation 
Cephalosporins 
0 3.333333 0 15.38462 28.57143 27.27273 0.0003 
urinary anti-infectives 0 10 0 10.25641 14.28571 9.090909 0.2595 
Miscellaneous Antibiotics 0 3.333333 8.823529 5.128205 4.761905 0 0.9621 
Penicillins  0 10 20.58824 15.38462 4.761905 18.18182 0.7034 
sulfonamides  0 23.33333 5.882353 0 0 0 0.0041 
Antibiotic Category 2012 2013 2014 2015 2016 2017 P-value  
Quinolones  66.66667 62.5 50 43.37349 51.28205 36.36364 <.0001 
Macrolides 0 4.166667 5.357143 1.204819 2.564103 3.030303 0.8719 
Tetracyclines 0 2.777778 0 1.204819 3.846154 3.030303 0.2159 
First generation 
Cephalosporins 
15 8.333333 16.07143 20.48193 32.05128 33.33333 0.0003 
Second generation 
Cephalosporins 
0 1.388889 1.785714 2.409639 3.846154 1.515152 0.3053 
Third generation 
Cephalosporins 
1.666667 6.944444 5.357143 8.433735 6.410256 15.15152 0.0273 
urinary anti-infectives 3.333333 1.388889 12.5 18.07229 10.25641 10.60606 0.0376 
Miscellaneous Antibiotics 3.333333 2.777778 0 0 0 1.515152 0.0951 
Penicillins  6.666667 11.11111 8.928571 6.024096 3.846154 4.545455 0.1019 
sulfonamides  13.33333 6.944444 8.928571 8.433735 0 3.030303 0.0027 
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Appendix 3.6 Antibiotic Treatment Among URI patients in Geriatrics Clinic Per 100 URI Diagnoses 
 
Appendix 3.7 Antibiotic Treatment Among URI patients in Internal Medicine Ambulatory Care Clinic Per 
100 URI Diagnoses 
 Antibiotic Category  2012 2013 2014 2015 2016 2017 P-value  
Quinolones 12.06897 10.41667 13.20755 19.14894 6.818182 5.063291 0.2113 
Macrolides 68.96552 68.75 64.15094 44.68085 53.40909 41.77215 0.0083 
Tetracyclines 0 4.166667 13.20755 6.382979 18.18182 27.8481 <.0001 
First generation 
Cephalosporins 
0 0 3.773585 0 1.136364 1.265823 0.5386 
Second generation 
Cephalosporins 
0 0 0 0 0 2.531646 0.0661 
Penicillins  18.96552 16.66667 11.32075 23.40426 19.31818 22.78481 0.1674 
sulfonamides  1.724138 0 1.886792 2.12766 0 0 0.3051 
 
  
 
 
  
 Antibiotic Category  2012 2013 2014 2015 2016 2017 P-value  
Quinolones 22.22222 17.24138 8.108108 25.92593 17.64706 0 0.562 
Macrolides 66.66667 65.51724 54.05405 50 52.94118 83.33333 0.6156 
Tetracyclines 5.555556 0 5.405405 1.851852 0 0 0.3586 
First generation 
Cephalosporins 
0 0 0 1.851852 5.882353 0 0.2485 
Second generation 
Cephalosporins 
0 6.896552 0 0 0 0 0.1566 
Penicillins  16.66667 13.7931 32.43243 22.22222 29.41176 16.66667 0.6303 
sulfonamides  0 0 2.702703 1.851852 0 0 0.9 
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Appendix 3.8 Antibiotic Treatment Among Skin & Soft Tissue patients in Geriatrics Clinic Per 100 Skin & Soft 
Tissue Diagnoses 
 Antibiotic Category  2012 2013 2014 2015 2016 2017 p-value  
Quinolones 0 12.5 28.57143 0 0 0 0.1818 
Macrolides 0 0 0 0 11.11111 0 0.4082 
Tetracyclines 62.5 62.5 28.57143 31.25 11.11111 26.66667 0.0161 
First generation 
Cephalosporins 
50 18.75 0 18.75 22.22222 66.66667 0.0618 
Third generation 
Cephalosporins 
0 0 0 6.25 0 0 0.8148 
Miscellaneous Antibiotics 0 0 28.57143 0 0 0 0.6098 
Penicillins  0 12.5 28.57143 50 33.33333 20 0.1114 
 
 
 
Appendix 3.9 Antibiotic Treatment Among Skin & Soft Tissue patients in Internal Medicine Ambulatory Care 
Clinic Per 100 Skin & Soft Tissue Diagnoses 
 Antibiotic Category  2012 2013 2014 2015 2016 2017 p-value  
Quinolones 10.52632 4.545455 0 0 0 0 0.0738 
Macrolides 0 0 0 0 15.38462 0 0.126 
Tetracyclines 57.89474 59.09091 71.42857 62.5 38.46154 50 0.8098 
First generation 
Cephalosporins 
21.05263 36.36364 50 12.5 30.76923 37.5 0.3642 
Penicillins  26.31579 22.72727 7.142857 12.5 7.692308 6.25 0.0158 
Sulfonamides  0 4.545455 7.142857 12.5 0 12.5 0.1585 
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Appendix For Study 3  
 
Appendix 4.10 The Trend of Infectious Disease Diagnoses Among Middle-Aged Adults visiting the ED per 10,000 visits 
Type of Infection 2012 2013 2014 2015 2016 2017 P-value  
UTI 136.5188 143.8404 145.7249 113.9997 106.3759 122.5476 0.0102 
URI 180.173 165.4938 150.9294 123.7314 75.79283 76.00306 <.0001 
Pneumonia 83.33995 103.6269 98.14126 89.67051 89.08982 102.5158 <.0001 
Skin Infection 76.99024 85.06689 87.73234 62.56082 53.18795 47.13368 0.1377 
C.Diff 0 0 0 0.69512 7.978193 8.248395 <.0001 
Otitis Media 0 18.56005 11.15242 10.4268 6.648494 7.070052 0.0433 
 
 
 Appendix 4.11 The Trend of Infectious Disease Diagnoses Among Older Adults visiting the ED per 10,000 visits  
 
  
Type of Infection 2012 2013 2014 2015 2016 2017 P-value  
UTI 256.523 265.8371 258.0223 230.1578 206.8732 244.2297 0.8107 
URI 98.21167 107.4661 104.7806 90.16491 44.08772 54.57148 <.0001 
Pneumonia 121.6652 173.9253 145.3831 151.8567 132.2632 152.9791 0.0381 
Skin Infection 71.82644 50.90498 62.86837 65.25092 37.305 65.30685 0.8792 
C.Diff 0 0 0 1.18638 21.47863 13.41922 <.0001 
Otitis Media 10.26092 7.070136 3.929273 4.745521 4.521818 4.473072 0.2189 
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 Appendix 4.12 The Trend of Antibiotic Prescriptions Among Older Adult  patients Visiting the ED per 10,000 visits 
 
 
 
 Appendix 4.13 The Trend of Antibiotic Prescriptions Among Middle-Aged patients Visiting the ED per 10,000 
visit 
  
Antibiotic Category 2012 2013 2014 2015 2016 2017 P-value  
Quinolones 215.0964 232.774 211.1524 229.3897 211.4221 206.2099 <.0001 
Macrolides 82.54623 92.02691 104.8327 105.6583 95.73832 138.4552 0.1265 
Tetracyclines 91.27709 81.20022 66.9145 66.03642 48.53401 75.41389 <.0001 
First generation Cephalosporins 181.7605 155.4404 150.1859 173.0849 182.8336 214.4583 0.6478 
Second generation Cephalosporins 13.49313 10.05336 14.86989 27.10969 20.61033 15.90762 0.53 
Third generation Cephalosporins 109.5325 111.3603 129.368 132.768 125.6565 177.3405 0.0482 
Aminopenicillins 12.69942 21.65339 25.27881 22.93897 25.26428 22.3885 0.7358 
urinary anti-infectives 9.524565 13.92004 10.40892 9.731684 9.972741 18.85347 0.5361 
Miscellaneous Antibiotics 70.64053 65.73351 81.04089 78.54859 81.77648 121.9584 0.0107 
Penicillins  179.3793 220.4006 240.1487 235.6458 278.5719 334.06 <.0001 
sulfonamides  40.4794 47.17346 38.66171 45.18282 43.88006 54.79291 0.7932 
Clindamycin 26.19255 29.38675 25.27881 22.93897 23.93458 28.86938 0.1383 
 
2012 2013 2014 2015 2016 2017 P-value  
Quinolones 400.1759 395.9276 411.2639 367.7779 334.6145 372.1596 <.0001 
Macrolides 76.22398 93.32579 87.75377 74.74196 101.7409 171.766 0.0043 
Tetracyclines 48.37291 52.319 43.222 68.81006 62.17499 67.9907 0.8911 
First generation Cephalosporins 162.7089 197.9638 179.4368 213.5485 229.4823 279.1197 0.2708 
Second generation Cephalosporins 14.65846 14.14027 9.168304 33.21865 22.60909 19.68152 0.7515 
Third generation Cephalosporins 256.523 263.009 226.5881 224.2259 256.6132 396.3142 0.7441 
Aminopenicillins 17.59015 14.14027 17.02685 33.21865 23.73954 26.83843 0.5824 
urinary anti-infectives 7.329229 15.5543 17.02685 16.60932 22.60909 43.83611 0.0003 
Miscellaneous Antibiotics 55.70214 97.56787 81.20498 98.46957 98.34954 124.3514 0.2425 
Penicillins  288.7716 349.2647 352.3248 387.9464 388.8763 541.2417 0.0142 
sulfonamides  30.78276 32.52262 41.91225 36.77779 33.91363 54.57148 0.7505 
Clindamycin 38.11199 29.69457 22.26588 30.84589 32.78318 29.52228 0.0338 
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Appendix 4.14 Antibiotic Treatment Among UTI Older Adult Patients Visiting the ED per 100 UTI Diagnoses 
Antibiotic Category  2012 2013 2014 2015 2016 2017 P-value  
Quinolones  22.28571 15.42553 22.33503 21.82741 11.47541 14.28571 <.0001 
Macrolides 0 1.595745 0.507614 0 3.278689 2.197802 0.0505 
Tetracyclines 0.571429 0 0 0.507614 0.546448 0 0.5952 
First generation Cephalosporins 9.142857 8.510638 8.629442 8.629442 11.47541 17.58242 0.0357 
Second generation 
Cephalosporins 
0.571429 1.06383 0 0 0 0 0.0263 
Third generation 
Cephalosporins 
32.57143 34.57447 28.93401 29.94924 38.79781 41.39194 0.9783 
urinary anti-infectives 0.571429 0.531915 3.553299 3.553299 6.010929 4.761905 0.0039 
Miscellaneous Antibiotics 0.571429 3.723404 4.060914 7.106599 1.639344 1.465201 0.3944 
Penicillins  6.285714 16.48936 17.25888 15.73604 13.6612 15.01832 0.8968 
sulfonamides  1.142857 1.06383 3.553299 3.553299 5.464481 4.029304 0.0502 
 
  
 
Appendix 4.15 Antibiotic Treatment Among UTI Middle-Aged Patients Visiting the ED per 100 UTI Diagnoses 
 
 
  
Antibiotic Category 2012 2013 2014 2015 2016 2017 P-value  
Quinolones  19.18605 27.41935 12.7551 19.5122 11.25 7.692308 <.0001 
Macrolides 0 1.075269 2.55102 1.829268 0 1.923077 0.3902 
Tetracyclines 0.581395 0 0.510204 0 0.625 0.961538 0.384 
First generation Cephalosporins 19.18605 15.5914 17.34694 21.95122 15.625 22.59615 0.3194 
Third generation 
Cephalosporins 
14.53488 31.72043 22.95918 23.17073 20 19.71154 0.5293 
urinary anti-infectives 1.744186 4.83871 5.612245 1.219512 3.75 8.173077 0.036 
Miscellaneous Antibiotics 2.906977 2.688172 6.632653 3.04878 1.875 5.288462 0.5626 
Penicillins  7.55814 8.064516 16.83673 10.36585 10 16.82692 0.0161 
sulfonamides  2.906977 6.451613 2.55102 4.268293 0.625 4.807692 0.6533 
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 Appendix 4.16 Antibiotic Treatment Among URI Older Adult Patients Visiting the ED per 100 URI Diagnoses 
 
 
 
Appendix 4.17 Antibiotic Treatment Among URI Middle-Aged Patients Visiting the ED per 100 URI Diagnoses  
 
 
 
  
Antibiotic Category 2012 2013 2014 2015 2016 2017 P-value  
Quinolones 8.955224 31.57895 13.75 21.05263 17.94872 5 0.0526 
Macrolides 7.462687 40.78947 23.75 21.05263 33.33333 26.66667 0.3746 
Tetracyclines 8.955224 6.578947 11.25 13.15789 5.128205 6.666667 0.6133 
First generation Cephalosporins 8.955224 1.315789 0 1.315789 0 1.666667 0.0084 
Third generation 
Cephalosporins 
2.985075 14.47368 8.75 3.947368 7.692308 6.666667 0.5236 
Penicillins  7.462687 5.263158 8.75 6.578947 12.82051 23.33333 0.0027 
Antibiotic Category 2012 2013 2014 2015 2016 2017 P-value  
Quinolones 14.43299 27.27273 18.64407 22.22222 10 13.75 0.8052 
Macrolides 65.97938 44.54545 39.83051 68.88889 41.25 50 0.1673 
Tetracyclines 48.45361 31.81818 21.18644 40 6.25 20 0.0015 
First generation Cephalosporins 2.061856 2.727273 0.847458 4.444444 1.25 3.75 0.3195 
Third generation 
Cephalosporins 
3.092784 1.818182 0.847458 0 0 2.5 0.4961 
Penicillins  5.154639 20 9.322034 17.77778 17.5 10 0.06 
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Appendix 4.18 Antibiotic Treatment Among Skin & Soft Tissue Older Adult Patients Visiting the ED per 100 Skin 
& Soft Tissue Diagnoses 
 
Antibiotic Category  2012 2013 2014 2015 2016 2017 p-value  
Quinolones 6.122449 5.555556 4.166667 1.818182 0 1.369863 0.0171 
Tetracyclines 6.122449 5.555556 4.166667 10.90909 6.060606 2.739726 0.273 
First generation Cephalosporins 8.163265 25 8.333333 14.54545 12.12121 31.50685 0.0676 
Third generation Cephalosporins 4.081633 0 2.083333 3.636364 3.030303 0 0.1924 
Penicillins  32.65306 33.33333 37.5 34.54545 54.54545 46.57534 0.6719 
Sulfonamides  0 5.555556 4.166667 5.454545 6.060606 5.479452 0.4076 
Clindamycin 10.20408 25 10.41667 18.18182 21.21212 16.43836 0.912 
 
 
 
Appendix 4.19 Antibiotic Treatment Among Skin & Soft Tissue Middle-Aged Patients Visiting the ED per 100 Skin 
& Soft Tissue Diagnoses 
 
Antibiotic Category 2012 2013 2014 2015 2016 2017 p-value  
Quinolones 6.185567 1.818182 1.694915 3.333333 3.75 5 0.9462 
Tetracyclines 7.216495 10 8.474576 6.666667 6.25 7.5 0.4686 
First generation Cephalosporins 18.5567 20 11.86441 18.88889 16.25 15 0.3092 
Third generation Cephalosporins 4.123711 0.909091 0.847458 0 0 5 0.8884 
Penicillins  18.5567 28.18182 23.72881 43.33333 18.75 45 0.006 
Sulfonamides  9.278351 9.090909 11.01695 4.444444 3.75 5 0.0379 
Clindamycin  28.57143 27.77778 43.75 32.72727 48.48485 19.17808 0.1167 
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Appendix 5.1. Detailed of antibiotic categories that we included in the analyses of study 
two and study three. 
Antibiotic Category  Medication Name  
008 Carbapenems  Doripenem, Doripenem, Ertapenem, 
Imipenem, Meropenem. 
009 Cephalosporin  All first generation cephalosporins,  
All second generation cephalosporins, All 
third generation cephalosporins, All fourth 
generation cephalosporins, All fifth 
generation cephalosporins.  
011 Macrolide  Azithromycin, Clarithromycin, Dirithromycin, 
Erythromycin 
012 Miscellaneous antibiotics  Aztreonam, Bacitacin, Chloramphenicol, 
Colistimethate, Fosfomycine, Metronidazole,   
013 Penicillins  All penicillinase resistant penicillins, 
Antipsudomonal penicellins, 
Aminopenicillins, Beta-lactamse inhibitors, 
Natural penicillins.  
014 Quinolones  Ciprofloxacin, Levofloxacin, Ofloxacin,  
015 Sulfonamides  Sulfadiazine, Sulfamethoxazole, 
Sulfamethoxazole-Trimethoprim, 
Sulfasalazine 
016 Tetracyclines  Doxycycline, Tetracycline,  
017 Urinary anti-infective  Fosfomycin, Nitrofurantoin, Trimethoprim 
240 Lincomycin  Clindamycin 
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